###begin article-title 0
###xml 82 99 <span type="species:ncbi:11103">hepatitis C virus</span>
RNase III cleavage demonstrates a long range RNA: RNA duplex element flanking the hepatitis C virus internal ribosome entry site
###end article-title 0
###begin p 1
###xml 606 645 606 645 <email xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">journals.permissions@oxfordjournals.org</email>
The online version of this article has been published under an open access model. Users are entitled to use, reproduce, disseminate, or display the open access version of this article for non-commercial purposes provided that: the original authorship is properly and fully attributed; the Journal and Oxford University Press are attributed as the original place of publication with the correct citation details given; if an article is subsequently reproduced or disseminated not in its entirety but only in part or as a derivative work this must be clearly indicated. For commercial re-use, please contact journals.permissions@oxfordjournals.org
###end p 1
###begin p 2
###xml 19 35 19 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 339 341 327 329 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">27</sup>
###xml 347 349 335 337 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">33</sup>
###xml 379 382 367 370 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">439</sup>
###xml 887 893 875 881 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E.coli</italic>
###xml 19 35 <span type="species:ncbi:562">Escherichia coli</span>
###xml 92 109 <span type="species:ncbi:11103">hepatitis C virus</span>
###xml 111 114 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 238 241 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 454 457 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 632 635 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 887 893 <span type="species:ncbi:562">E.coli</span>
###xml 927 943 <span type="species:ncbi:10760">bacteriophage T7</span>
###xml 990 993 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 1422 1425 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
Here, we show that Escherichia coli Ribonuclease III cleaves specifically the RNA genome of hepatitis C virus (HCV) within the first 570 nt with similar efficiency within two sequences which are approximately400 bases apart in the linear HCV map. Demonstrations include determination of the specificity of the cleavage sites at positions C27 and U33 in the first (5') motif and G439 in the second (3') motif, complete competition inhibition of 5' and 3' HCV RNA cleavages by added double-stranded RNA in a 1:6 to 1:8 weight ratio, respectively, 50% reverse competition inhibition of the RNase III T7 R1.1 mRNA substrate cleavage by HCV RNA at 1:1 molar ratio, and determination of the 5' phosphate and 3' hydroxyl end groups of the newly generated termini after cleavage. By comparing the activity and specificity of the commercial RNase III enzyme, used in this study, with the natural E.coli RNase III enzyme, on the natural bacteriophage T7 R1.1 mRNA substrate, we demonstrated that the HCV cuts fall into the category of specific, secondary RNase III cleavages. This reaction identifies regions of unusual RNA structure, and we further showed that blocking or deletion of one of the two RNase III-sensitive sequence motifs impeded cleavage at the other, providing direct evidence that both sequence motifs, besides being far apart in the linear RNA sequence, occur in a single RNA structural motif, which encloses the HCV internal ribosome entry site in a large RNA loop.
###end p 2
###begin title 3
INTRODUCTION
###end title 3
###begin p 4
###xml 111 112 111 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b1">1</xref>
###xml 157 169 157 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flaviviridae</italic>
###xml 171 172 171 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b1">1</xref>
###xml 430 431 430 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b1">1</xref>
###xml 534 535 534 535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b2">2</xref>
###xml 536 537 536 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b3">3</xref>
###xml 676 677 676 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b2">2</xref>
###xml 678 679 678 679 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b4">4</xref>
###xml 818 819 818 819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b5">5</xref>
###xml 820 821 820 821 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b7">7</xref>
###xml 1122 1123 1122 1123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b8">8</xref>
###xml 1124 1126 1124 1126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b11">11</xref>
###xml 4 21 <span type="species:ncbi:11103">hepatitis C virus</span>
###xml 23 26 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 33 38 <span type="species:ncbi:9606">human</span>
###xml 93 99 <span type="species:ncbi:9606">people</span>
###xml 475 478 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 593 596 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 785 788 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
The hepatitis C virus (HCV) is a human pathogen causing chronic liver disease in 170 million people worldwide (1). The virus is classified within the family flaviviridae (1). The RNA genome begins with a 5'-untranslated region (5'-UTR) that extends from position 1 to the AUG at position 342, continues in the core (C) coding region which is the first coding locus of a long open reading frame and ends in a 3' non-coding region (1). The secondary structure of the 5'-UTR of HCV has been extensively studied since the early nineties (2,3). Biochemical and functional studies revealed that the HCV 5'-UTR folds into a highly ordered complex structure with multiple stem loops (2-4) containing two distinct RNA elements, a short 5'-proximal RNA element (nucleotides 1-43) that regulates HCV replication and translation (5-7) (domain I) and a longer internal ribosome entry site (IRES) element, including nucleotides 44-370 and forming domains II, III and IV. Mutational analysis has revealed that maintenance of the IRES structural domains is critical for cap-independent initiation of translation of the viral polyprotein (8-11).
###end p 4
###begin p 5
###xml 129 131 129 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b12">12</xref>
###xml 294 296 294 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b13">13</xref>
###xml 297 299 297 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b14">14</xref>
###xml 354 359 354 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 362 364 362 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b15">15</xref>
###xml 441 443 441 443 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">34</sup>
###xml 445 447 445 447 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 478 480 478 480 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">34</sup>
###xml 482 484 482 484 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 518 520 518 520 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">34</sup>
###xml 522 524 522 524 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 884 886 884 886 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b15">15</xref>
###xml 1204 1206 1204 1206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b16">16</xref>
###xml 1213 1218 1213 1218 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 14 17 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 50 53 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 1194 1197 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
Comparison of HCV 5'-UTR sequences from different HCV genotypes has revealed that variation is very limited to particular sites (12). The sites of genotype variability are usually covariant substitution sites and they maintain the base paring required for the 5'-UTR secondary structure model (13,14). There is an interesting exception reported by Honda et al. (15) in an apparently unpaired region, between positions 21 and 43 where bases A34 G35 in genotype 1b correspond to G34 A35 in genotype 1a. The presence of A34 G35 has been associated with a 2-fold decrease of the translational efficiency in genotype 1b. This difference was only observed when the translated fragment contained the region downstream the AUG codon, supporting the idea of a long distance RNA-RNA interaction between the region containing the AG dinucleotide preceding the IRES and the capsid coding region (15). Subsequently, it was observed that mutations introduced to decrease hypothetical Watson-Crick base pairing between bases 24-38 and 428-442 could affect levels of IRES-mediated translation, and that compensatory mutations in this complementary motif re-established normal levels of translation directed by HCV IRES (16). Kim et al. proposed a hypothetical double-stranded RNA (dsRNA) motif whose duplex stability could regulate IRES activity. Nevertheless, direct structural proof for these kinds of proposals, derived from the evolutionary and sequence correlations, is lacking.
###end p 5
###begin p 6
###xml 64 80 64 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 82 84 82 84 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b17">17</xref>
###xml 85 87 85 87 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b18">18</xref>
###xml 282 284 282 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b19">19</xref>
###xml 285 287 285 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b20">20</xref>
###xml 560 562 560 562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b20">20</xref>
###xml 656 658 656 658 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b21">21</xref>
###xml 709 715 709 715 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E.coli</italic>
###xml 873 875 873 875 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b21">21</xref>
###xml 1197 1199 1197 1199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b21">21</xref>
###xml 1266 1268 1266 1268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b22">22</xref>
###xml 1351 1353 1351 1353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b23">23</xref>
###xml 1585 1592 1573 1580 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1625 1627 1613 1615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b24">24</xref>
###xml 64 80 <span type="species:ncbi:562">Escherichia coli</span>
###xml 638 654 <span type="species:ncbi:10760">bacteriophage T7</span>
###xml 709 715 <span type="species:ncbi:562">E.coli</span>
RNase III was discovered in 1967 as the third RNase activity of Escherichia coli (17,18). It was defined as a specific dsRNase that cleaved regions of 20 or more base pairs of RNA-RNA duplex structure and shown to participate in several RNA processes, including maturation of rRNA (19,20). RNase III may also cleave certain other specific regions with less perfect base pairings, which invariably contain approximately two turns of more or less regular dsRNA and additional sequence or structural elements which determine the way these substrates are cleaved (20). A well-studied example is the processing of the early mRNA region of the bacteriophage T7 (21). A set of specific cleavage reactions carried by E.coli RNase III enzyme which are favored at high enzyme:substrate ratios and at lower, rather than higher, monovalent cation concentration was discovered in 1976 (21). These were referred to as secondary cleavages; they behave like primary cleavages in the following way: they are effectively inhibited by dsRNA competitors for RNase III primary cuts; they are not inhibited by large molar excess of ssRNA and they are reproducible and specific, yielding 5' phosphates and 3' hydroxyls (21). In two well-characterized RNase III substrates, the T7 1.1mRNA (22) (between genes 1.0 and 1.1 of T7 early region) and a region next to T7 1.2 mRNA (23), primary and secondary cleavages occur in the opposite side of a hairpin loop approximately20 bp long, in a central region where the base pairing is less regular. Some secondary cleavages, such as that of R1.2 T7 mRNA, take place in vivo, although only 40% of the time (24).
###end p 6
###begin p 7
###xml 155 161 155 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E.coli</italic>
###xml 776 778 776 778 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">27</sup>
###xml 784 786 784 786 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">33</sup>
###xml 850 853 850 853 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">439</sup>
###xml 76 79 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 155 161 <span type="species:ncbi:562">E.coli</span>
###xml 389 392 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
Here, we found that two linked RNase III secondary cleavage sites flank the HCV IRES of genotype 1b. We also report that the two cleavages are specific to E.coli RNase III and show where the cleavages occur and the category into which they fall. Special caution was exercised because of using a commercial RNase III preparation that arises from cleavage of fusion proteins, to ensure that HCV cleavages are not the result of accompanying RNases or an artificial broadening of RNase III specificity. Finally, we report that the sequences carrying both cleavage sites interact to construct a single RNase III signal. This provides a direct proof for the presence of a structural motif with dsRNA characteristics between a region immediately preceding the IRES around positions C27 and U33 and a complementary downstream sequence surrounding positions G439.
###end p 7
###begin p 8
###xml 139 141 139 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b16">16</xref>
###xml 174 176 174 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b15">15</xref>
###xml 35 38 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 213 216 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
Taken together, the sensitivity of HCV RNA to RNase III described here represents the structural correlate of previous functional studies (16) and evolutionary observations (15) that allow us to conclude that the HCV IRES is embedded in a larger RNA structure.
###end p 8
###begin title 9
MATERIALS AND METHODS
###end title 9
###begin title 10
RNase III enzyme
###end title 10
###begin p 11
###xml 68 70 68 70 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b18">18</xref>
###xml 154 157 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
RNase III enzymes were obtained from commercial or natural sources (18). Commercial Ambion enzyme was the one used for most of the experiments related to HCV RNA structure. Commercial enzymes from New England Biolabs and Epicenter were used as indicated in Results. Natural RNase III enzyme was obtained from a phosphocellulose column peak or from a DEAE-Sephadex column peak and was used to evaluate the specificity of the commercial Ambion enzyme under our reaction conditions.
###end p 11
###begin title 12
RNA transcripts
###end title 12
###begin p 13
###xml 254 255 254 255 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 276 277 276 277 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 295 296 295 296 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 656 658 656 658 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b25">25</xref>
###xml 22 25 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 131 134 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 208 211 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 708 724 <span type="species:ncbi:10760">bacteriophage T7</span>
The DNA templates for HCV RNA transcripts were derived from the plasmid vector pN (1-4728) Bluescript, which contains nt 1-4728 of HCV under the T7 promoter. All RNA transcripts include the first base of the HCV genome and end at positions 402 (Aat-II) S3, 466 (PCR product) S2 and 570 (Blp-I) S1. The PCR product ending at base 466 was generated by amplification of pN (1-4728) with upstream primer (5'-CGCGGATCCTAATACGACTCACTATAGGCCGCCCCGATTGGGGGCGA-3' (which serves to introduce the T7 promoter in the PCR product) and a downstream primer (5'-GGGCCCCTGCGCGGCAACAG-3'). The T7 R1.1 RNA transcript used is a truncated version of the one described before (25). The RNA product is 60 nt long and contains the bacteriophage T7 'R1.1' primary and secondary cleavage sites.
###end p 13
###begin title 14
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
In vitro transcription
###end title 14
###begin p 15
###xml 109 117 105 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 150 152 136 138 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 697 699 673 675 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 738 740 714 716 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b26">26</xref>
To obtain the internally labeled substrates for cleavage assays, 1-2 microg of DNA template were transcribed in vitro (1 h at 37degreesC) with [alpha-32P]GTP followed by a 5 min treatment with RNase-free DNase I at 37degreesC. Cellulose CF11 chromatography was used to eliminate DNA fragments and non-incorporated nucleotides. Transcripts were then purified by gel electrophoresis under denaturing conditions on 4% polyacrylamide gels containing 7 M urea. Bands were visualized by autoradiography, excised from the gel and eluted in buffer 100 mM Tris-HCl, pH 7.5 and 10 mM EDTA, pH 7.5. The concentration of radioactive transcripts was determined by calculating the amount of incorporated [alpha-32P]GTP based on scintillation counting (26).
###end p 15
###begin p 16
'Low specific activity' labeled RNA transcripts were made by scaling up by 40-fold the transcription reaction described above, and with 1/100 of the concentration of the radioactive nucleotide.
###end p 16
###begin title 17
Obtaining of 5' end-labeled and 3' end-labeled transcripts
###end title 17
###begin p 18
Unlabeled 'cold' transcripts prepared in standard transcription reactions without added radioactive nucleotide label were subsequently reacted as follows.
###end p 18
###begin title 19
3' End labeling
###end title 19
###begin p 20
###xml 76 78 76 78 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 195 196 191 192 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Aliquots containing 40 U T4 RNA ligase and a molar ratio of 2:1 pmol of 5' [32P]pCp with respect to RNA were mixed. The reaction was carried out in 30 microl of 50 mM Tris-HCl, pH 7.5, 10 mM MgCl2, 10 mM DTT, 1 mM ATP, 0.01% BSA and 10% dimethyl sulfoxide, RNasin (20 units) and T4 RNA ligase (40 units). The reaction mixture was incubated 4 days at 4degreesC. The labeled RNA was purified again using the electrophoretic procedure described above.
###end p 20
###begin title 21
5' End labeling
###end title 21
###begin p 22
###xml 40 42 36 38 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 157 159 145 147 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 291 292 275 276 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 312 313 296 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</italic>
Reactions were carried out using [alpha-32P]GTP and the enzyme guanylyl transferase, and followed the same purification procedure. First, 8 microl of [alpha-32P]GTP were dried in a Speedvac. Meanwhile, the reaction mixture (20 microl) contained 50 mM Tris-HCl, pH 8.0, 6 mM KCl, 1.2 mM Mg Cl2, 1 U RNasin, 50 nM S-Adenosyl-Methionine (Sigma) and 10 nM DTT was prepared. Finally, the 'cold' RNA transcript is added to a 2.5 microM final concentration. This capping reaction was initiated by the addition of 1 microl guanylyl transferase (recombinant enzyme provided by J. Martinez) and incubated at 37degreesC for 4 h. The reaction was stopped by the addition of 2 vol of loading buffer (0.3% Bromophenol Blue, 0.3% Xilene-cianol, 10 mM EDTA pH, 7.5 and 97.5% desionized formamide) and the transcript was purified by denaturing polyacrylamide gel electrophoresis using the procedure described above.
###end p 22
###begin title 23
RNase III cleavage assay: standard and working conditions
###end title 23
###begin p 24
###xml 92 93 92 93 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 111 112 111 112 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 607 608 601 602 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 622 623 616 617 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 770 776 760 766 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E.coli</italic>
###xml 188 191 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 334 337 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 442 445 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 770 776 <span type="species:ncbi:562">E.coli</span>
###xml 835 840 <span type="species:ncbi:4932">yeast</span>
Standard RNase III conditions include a buffer containing 0.01 M Tris-HCl, pH 7.6, 0.13 M NH4Cl and 0.01 M MgCl2. The salt and buffer conditions used for all of our initial experiments on HCV RNA cleavage by RNase III were the same used previously to detect RNase P cleavage of a tRNA-like structure near the AUG start triplet in the HCV IRES. These are not standard RNase III conditions and are referred in the text as 'working conditions'. HCV RNA substrate (0.6 nM final concentration) was pre-heated at 90degreesC for 1 min, before the addition of reaction buffer [10 mM HEPES-KOH, pH 7.5, 10 mM Mg(OAc)2 and 100 mM NH4(OAc)] and left to cool down to room temperature. Cleavage reactions were performed with 20 U RNAsin, and 0.0005 U/microl (final concentration) of E.coli RNase III (Ambion), in the presence of 1 microg/microl of yeast tRNA, and were carried out at 37degreesC in a volume of 10 microl for 1 h. These optimal conditions were used in all of the experiments. Cleavage products were separated on denaturing polyacrylamide gels and visualized by autoradiography.
###end p 24
###begin p 25
Quantitative data relating to RNase III cleavage kinetics were obtained using a Radioisotopic Image Analyser BAS-1800 (Fuji film). The percentage of uncleaved material was calculated as the ratio of uncleaved material/starting material.
###end p 25
###begin title 26
RNA sequencing with partial nuclease digestion
###end title 26
###begin title 27
Partial RNase T1 digestion assays on 5' labeled transcripts
###end title 27
###begin p 28
###xml 26 27 26 27 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
Aliquots containing 2 x 104 Cerenkov c.p.m. of the Cap-5'-Labeled RNA transcripts were mixed with 2.5 microg carrier tRNA in 1 mM Tris-HCl (pH 7.5) and 1 mM EDTA (final concentration). Cleavage reactions were initiated by the addition of 0.1 microg RNase T1 and incubated at 37degreesC for 20 min in a final reaction volume of 10 microl.
###end p 28
###begin title 29
Nuclease P1 assays on end-labeled transcripts
###end title 29
###begin p 30
###xml 84 85 68 69 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 183 184 163 164 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 209 210 189 190 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 376 378 336 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b27">27</xref>
For RNase reactions, the digestion mixture (10 microl) contained approximately2 x 104 Cerenkov c.p.m. of the 5' or 3' end-labeled transcript and 2.5 microg of carrier tRNA in 40 mM NH4OAc (pH 5.3), 0.4 mM ZnS04 during 5 min at 70degreesC. Cleavage reactions were initiated by the addition of 0.001 microg/microl nuclease P1 (Calbiochem) and incubated at 70degreesC for 1 min (27).
###end p 30
###begin title 31
Alkaline hydrolysis reactions
###end title 31
###begin p 32
###xml 22 23 22 23 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 118 119 114 115 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 122 123 118 119 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 125 126 121 122 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 173 175 163 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b27">27</xref>
Aliquots containing 104 Cerenkov c.p.m. of end-labeled RNA were incubated with 2 microg of carrier tRNA in 0.2 M NaHCO3-Na2CO3 (pH 9) and 1 mM EDTA for 5 min at 90degreesC (27).
###end p 32
###begin p 33
All reactions were stopped with 1 vol of loading buffer and maintained in dry ice until loading in 4% polyacrylamide-urea sequencing gel.
###end p 33
###begin title 34
Circularization assay
###end title 34
###begin p 35
The pre-labeled P2 was incubated with T4 RNA ligase using the same conditions described above (see 3' end-labeled transcript), and the reaction was carried out in 10 microl final volume. In a later step, this reaction was treated with 2.5 microg tRNA, 30 mM EDTA, 3% SDS and 0.5 mg proteinase K (previously pre-heated at 65degreesC for 1 min) at 65degreesC for 5 min. After phenol treatment and precipitation with acetate and ethanol, the results were visualized on 4% denaturing polyacrylamide gel.
###end p 35
###begin title 36
Polynucleotide kinase labeling
###end title 36
###begin p 37
The product bands purified by preparative gel electrophoresis were labeled using the Kinase Max Kit (Ambion).
###end p 37
###begin title 38
Competitive reactions
###end title 38
###begin title 39
Competitive inhibition
###end title 39
###begin p 40
###xml 172 195 172 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Penicillium chrysogenum</italic>
###xml 71 74 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 172 195 <span type="species:ncbi:5076">Penicillium chrysogenum</span>
###xml 231 234 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
The experiments consisted of incubating the same amount of end-labeled HCV transcript with increasing concentrations of dsRNA (of substantial length, from a virus grown in Penicillium chrysogenum) from 2- to 12-fold to inhibit the HCV RNA cleavages. The conditions for assaying RNase III cleavage are described above. Poly(I-C) (Sigma) was used for other reactions.
###end p 40
###begin title 41
Reverse competitions
###end title 41
###begin p 42
###xml 113 116 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
The internally labeled transcript R1.1 is incubated with increasing concentrations (from 1/4- to 4-fold) of cold HCV RNA in the same conditions described above.
###end p 42
###begin title 43
RNA fingerprinting
###end title 43
###begin p 44
###xml 57 59 53 55 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 226 228 222 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b28">28</xref>
Oligonucleotides created by RNase T1 digestion of [alpha-32P]GTP labeled R1.1 RNA were fractionated to yield 2D fingerprints [first dimension by electrophoresis and second by homocromatography exactly as described previously (28)].
###end p 44
###begin title 45
RESULTS
###end title 45
###begin title 46
###xml 12 15 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
Cleavage of HCV RNA transcripts
###end title 46
###begin p 47
###xml 0 8 0 8 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1</xref>
###xml 75 76 75 76 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 79 80 79 80 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 86 87 86 87 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 297 298 297 298 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 308 309 308 309 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 322 323 322 323 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 334 340 334 340 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E.coli</italic>
###xml 377 378 377 378 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 428 437 428 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2A</xref>
###xml 455 464 455 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2B</xref>
###xml 492 501 492 501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2C</xref>
###xml 548 549 548 549 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 640 641 640 641 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 773 774 773 774 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 806 815 806 815 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2D</xref>
###xml 39 42 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 207 210 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 334 340 <span type="species:ncbi:562">E.coli</span>
Figure 1 is a schematic drawing of the HCV genome, above which appear the S1, S2 and S3 transcripts located at the 5'-UTR and the first one-third of the Core coding region, all starting at position 1 of the HCV genome. The substrates are consecutively shortened at their 3' ends (position 570 in S1, 466 in S2 and 402 in S3). Initial E.coli RNase III experiments involved the S1 substrate transcript, either internally labeled (Figure 2A), 'cap' labeled (Figure 2B) or labeled at its 3' end (Figure 2C) subsequent experiments utilized the shorter S2 transcript, labeled in the same way (data not shown), allowing us to distinguish between S1 partial cleavage products P1-P2 and P2-P3 or complete digestion products P1, P2 and P3, and to position the cleavage sites in the S1 570-base fragment, as shown in Figure 2D. Additional bands that may be seen in the gel, which are not explored in the present work, are dependent on higher RNase III concentration and may correspond to less sensitive sites for RNase III.
###end p 47
###begin title 48
###xml 33 36 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
RNase III is responsible for the HCV RNA cuts
###end title 48
###begin p 49
###xml 966 972 966 972 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E.coli</italic>
###xml 1023 1025 1023 1025 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b18">18</xref>
###xml 1026 1028 1026 1028 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b21">21</xref>
###xml 37 40 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 680 683 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 774 777 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 966 972 <span type="species:ncbi:562">E.coli</span>
###xml 1069 1085 <span type="species:ncbi:10760">bacteriophage T7</span>
The key experimental question of the HCV RNA cleavages obtained in the reactions involving commercial RNase III is whether the cleavages are performed by RNase III itself, rather than by a co-purified contaminant activity. The commercial RNase III used in this study arises by cleavage of fusion protein and is purified through various steps with a focus on dsRNA cleavage, rather than the processing of long ssRNA with a few specific sites for cleavage. This leaves open the possibility of contamination by traces of conventional RNases, which can cleave ssRNA, or that the recombinant enzyme had acquired a subtly broadened specificity. In order to determine the specificity of HCV cleavages by RNase III in this work, two series of experiments were performed: one on the HCV RNA-RNase III reaction and its cleavage products (classified as direct and indirect methods, respectively); the other comparing the action of commercial RNase III preparations and natural E.coli RNase III enzyme purified by standard techniques (18,21) on the well-known RNAse III substrate, bacteriophage T7 R1.1 mRNA.
###end p 49
###begin title 50
Direct method: end group determination and cleavage precision by RNA sequencing
###end title 50
###begin title 51
Specific cleavage positions
###end title 51
###begin p 52
###xml 206 208 206 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b23">23</xref>
###xml 209 211 209 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b25">25</xref>
###xml 212 214 212 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b29">29</xref>
###xml 215 217 215 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b30">30</xref>
###xml 32 35 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 74 77 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
If RNase III is responsible for HCV RNA cleavage and if it were to cleave HCV RNA with the same specificity as it does other substrates, the site of cleavage should be between precise nucleotide positions (23,25,29,30).
###end p 52
###begin title 53
Cleavage site within the first (5') domain
###end title 53
###begin p 54
###xml 24 25 24 25 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 57 59 53 55 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 191 197 187 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E.coli</italic>
###xml 322 323 318 319 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 366 367 362 363 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 491 500 487 496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3A</xref>
###xml 548 549 544 545 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 575 583 571 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3</xref>
###xml 749 750 745 746 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 776 778 772 774 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">27</sup>
###xml 784 786 780 782 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">28</sup>
###xml 815 817 811 813 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">33</sup>
###xml 823 825 819 821 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">34</sup>
###xml 191 197 <span type="species:ncbi:562">E.coli</span>
Non-radioactive (cold) S1 was 5' end-labeled with [alpha-32P]GTP in the presence of guanylyl transferase and purified by gel electrophoresis. A fraction of the labeled RNA was incubated with E.coli RNase III and another fraction was subjected to partial digestion with nuclease P1, or to partial hydrolysis with alkali (OH-). RNase III products and partial P1 and OH- products were run in parallel on 20% acrylamide gels. Two product bands appeared in close proximity in the RNase III lane (Figure 3A, lane 2). In relation to the mobility of the OH- and P1 partial products (Figure 3, lanes 3 and 4, respectively), and counting from the first band, it was possible to conclude that RNase III is cleaving the phosphosdiester bond of a percentage of S1 molecules between bases C27 and C28 and the rest between bases U33 and A34. The percentage of molecules cleaved at one or the other position varied between different cleavage reactions, probably because of small experimental variation (data not shown).
###end p 54
###begin title 55
Cleavage site within the second (3') domain
###end title 55
###begin p 56
###xml 95 96 95 96 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 211 212 211 212 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 218 226 218 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1</xref>
###xml 235 236 235 236 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 279 281 275 277 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 352 353 348 349 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 366 367 362 363 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*</sup>
###xml 417 418 413 414 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*</sup>
###xml 507 508 503 504 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 544 545 540 541 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*</sup>
###xml 629 630 625 626 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*</sup>
###xml 706 709 702 705 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">441</sup>
###xml 715 724 711 720 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3B</xref>
###xml 787 788 783 784 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*</sup>
###xml 790 805 786 801 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3C and D</xref>
###xml 873 876 869 872 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">439</sup>
###xml 882 885 878 881 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">440</sup>
Because the RNase III cleavage site in the second (3') domain was apparently too far from the S1 3' end to discriminate its exact position in a sequencing gel, we prepared a shortened transcript at its 3' end, S2 (see Figure 1). Cold S2 transcript was 3' end labeled with [alpha-32P]pCp and T4 RNA ligase. The downstream RNase III cleavage product of S2 was named P3* since it is a shortened version of product P3. P3* was gel purified and subjected to partial digestion with T1 RNase and hydrolysis with OH-. The electrophoretic mobility of P3* corresponds to a fragment with two additional bases (counting from the 3' end of P3*) than the partial fragment generated by the T1 after cleaving at position G441 (see Figure 3B legend and the list of the T1-resistant oligonucleotides of P3*, Figure 3C and D). This result located the distal RNase III cleavage between bases G439 and A440.
###end p 56
###begin p 57
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E.coli</italic>
###xml 0 6 <span type="species:ncbi:562">E.coli</span>
E.coli RNAse III cleaves perfect dsRNA sequences of low complexity and many other substrates leaving 2 nt overhands products. The pattern of cleavage of the duplex at sites 27/439 differs from the general pattern of cleavage of a regular dsRNA at a given target site. Nevertheless, in cases where secondary RNAse III cleavage sites have been mapped, as in the R1.1 and R1.3 T7 RNA substrates, cleavages may produce a variety of extremes.
###end p 57
###begin title 58
Biochemical characterization
###end title 58
###begin p 59
###xml 101 102 101 102 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 124 126 124 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b23">23</xref>
###xml 127 129 127 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b31">31</xref>
###xml 333 335 333 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b32">32</xref>
###xml 336 338 336 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b33">33</xref>
One of the distinctive properties of RNase III is that it releases cleavage products containing 5' PO4 and 3'OH end groups (23,31). Contaminating RNases almost invariably cleave to yield 5' hydroxyl and 2', 3' phosphate end groups, and very few RNases cleave the phosphodiester backbone through the same mechanism used by RNase III (32,33). To identify the end group of the reaction products we carried out two different kinds of experiments. One was an enzymatic approach; the other, based on electrophoretic mobility.
###end p 59
###begin title 60
Enzymatic approach
###end title 60
###begin p 61
###xml 31 33 27 29 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 227 229 223 225 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 243 245 235 237 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 481 482 473 474 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 615 616 607 608 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 901 902 893 894 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 1107 1109 1095 1097 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 1222 1231 1210 1219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4A</xref>
###xml 1299 1308 1287 1296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4B</xref>
###xml 1414 1416 1398 1400 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 1524 1533 1508 1517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4B</xref>
###xml 1574 1583 1558 1567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4B</xref>
###xml 1749 1758 1733 1742 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4C</xref>
T4 RNA ligase may add a [alpha-32P]pCp nucleotide to the 3' OH end of an RNA fragment, and also may circularize terminal RNA fragments ending with a 5' P and a 3' OH. On the other hand, T4 polynucleotide kinase can introduce a 32P from [gamma-32P]ATP into the 5' end of an RNA fragment only if that end already has a 5' OH, or has been previously dephosphorylated by treatment with a phosphatase. From all total and partial cleavage products generated after RNase III cleavage of S1, P2 has the two newly generated termini. Thus, efforts were first concentrated on the determination of the end groups of P2. Thus, S1 was labeled at low specific radioactivity (enough to trace its electrophoretic mobility but low enough to permit an increase of incorporated radioactivity in the subsequent end-labeling reactions with the RNA ligase or polynucleotide kinase). Product band P2 was purified from other S1 cleavage products after electrophoresis, and the recovered radioactivity was divided into three aliquots. The resulting RNA was proven to be (i) actively labeled at its 3' end by T4 RNA ligase and [alpha-32P]pCp, as shown by an increase in the label in the autoradiogram in the lane representing the starting material (Figure 4A, lane 2) as compared with that subsequently treated by the ligase (Figure 4B, lane 1), demonstrating a 3' OH end; (ii) labeled in the 5' end with T4 polynucleotide kinase and [gamma-32P]ATP preferentially when it was previously dephosphorylated by treatment with alkaline phosphatase enzyme (Figure 4B, lane 1) compared with when it was not (Figure 4B, lane 2), demonstrating the presence of a phosphate group in its 5' end; (iii) circularized when incubated with T4 RNA ligase. In the electrophoresis autoradiogram (Figure 4C), it was possible to observe a more slowly migrating band (lane 2) in relation to untreated material (lane 1) that corresponds to circularized P2, proving in a single reaction the specific chemistry of RNase III reflected in both end groups at once.
###end p 61
###begin p 62
###xml 127 128 127 128 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
The end-labeling or circularizing experiments described above were also performed on total and partial digestion fragments of S1 (data not shown) proving the appropriate chemical groups: specifically, RNA ligase was able to label the 3' end of P1, P2 and P1-P2. Dephosphorylation-dependent kinasing was demonstrated in P2 and P2-P3. Circularization was also demonstrated in P2-P3, but failed as expected in P1-P2, because of the presence of a 5' pppG in P1 (pppG is not a substrate for RNA ligase).
###end p 62
###begin title 63
Electrophoretic mobility
###end title 63
###begin p 64
###xml 291 292 291 292 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 304 306 304 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b27">27</xref>
###xml 501 502 501 502 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 572 581 572 581 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4D</xref>
###xml 619 620 619 620 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 636 637 636 637 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 657 665 657 665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1</xref>
###xml 938 939 938 939 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*</sup>
###xml 908 911 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
This second approach was based on the different electrophoretic motilities of RNA molecules depending on the nature of the chemical end group. Alkaline hydrolysis releases products with 5' OH and a 2'-3' cyclic phosphate ends, while nuclease P1 releases products with changed polarity: 5' PO4 and 3' OH (27). Electrophoretic mobility of the products from P1 digestion labeled at their 5' ends were compared, in sequencing gels, with the mobility of a product ladder generated by partial digestion of S1 substrate with alkali or with P1 nuclease. The arrows on the left of Figure 4D indicate the position of the two 5' S1 products (see S1 cleavage scheme in Figure 1); the mobility is parallel to P1 nuclease products (lane 3), in agreement with the hypothesis that RNase III cleavage has occurred, producing 5' phosphate end groups. Only the end-groups of the shortest products of the RNase III treatment of HCV IRES substrates, P1 and P1*, could be tested in this kind of analysis, which is limited by the resolution of the sequencing gels.
###end p 64
###begin title 65
Indirect methods: competitive and reverse competitive inhibition
###end title 65
###begin p 66
###xml 164 165 164 165 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 171 172 171 172 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 515 537 511 533 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competitive inhibition</italic>
###xml 615 616 611 612 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 765 766 761 762 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 977 1000 973 996 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Penicillium chrysogenum</italic>
###xml 1041 1047 1037 1043 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E.coli</italic>
###xml 1059 1061 1055 1057 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b30">30</xref>
###xml 1062 1064 1058 1060 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b31">31</xref>
###xml 1202 1203 1198 1199 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 1394 1403 1390 1399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Figure 5A</xref>
###xml 1449 1458 1445 1454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Figure 5B</xref>
###xml 1506 1507 1502 1503 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 515 1555 511 1551 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="67"><italic>Competitive inhibition</italic>. This experiment consisted of incubating the same amount of labeled HCV RNA S<sub>1</sub> with increasing concentrations of cold natural dsRNA (from 2- to 12-fold excess) to inhibit HCV RNA cleavages. &#8216;Cap&#8217; labeled or 3&#8242; end-labeled HCV S<sub>1</sub> RNAs were used, respectively, as appropriate to follow the P1 or P3 short product fragments in 14% and 20% polyacrylamide gels. As RNA competitor we employed a dsRNA of substantial length from a virus grown in <italic>Penicillium chrysogenum</italic> (PC RNA) which is a known substrate for <italic>E.coli</italic> RNase III (<xref ref-type="bibr" rid="b30">30</xref>,<xref ref-type="bibr" rid="b31">31</xref>). When this unlabeled (cold) dsRNA, from 20 to 120 ng, was included in the RNase III cleavage reactions of &#8216;cap&#8217; labeled and 3&#8242; labeled S<sub>1</sub>, the amounts of HCV cleavage products were decreased with increased competitor concentration and reached total inhibition at a weight ratio of 1 to 6 PC RNA/HCV RNA for the 5&#8242; end cleavage (<xref ref-type="fig" rid="fig5">Figure 5A</xref>, lane 6) and 1 to 8 for the 3&#8242; end cleavage (<xref ref-type="fig" rid="fig5">Figure 5B</xref>, lane 7). Similar results were obtained using S<sub>2</sub> as a substrate for both sites (data not shown).</p>
###xml 515 1555 511 1551 <list-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="67"><italic>Competitive inhibition</italic>. This experiment consisted of incubating the same amount of labeled HCV RNA S<sub>1</sub> with increasing concentrations of cold natural dsRNA (from 2- to 12-fold excess) to inhibit HCV RNA cleavages. &#8216;Cap&#8217; labeled or 3&#8242; end-labeled HCV S<sub>1</sub> RNAs were used, respectively, as appropriate to follow the P1 or P3 short product fragments in 14% and 20% polyacrylamide gels. As RNA competitor we employed a dsRNA of substantial length from a virus grown in <italic>Penicillium chrysogenum</italic> (PC RNA) which is a known substrate for <italic>E.coli</italic> RNase III (<xref ref-type="bibr" rid="b30">30</xref>,<xref ref-type="bibr" rid="b31">31</xref>). When this unlabeled (cold) dsRNA, from 20 to 120 ng, was included in the RNase III cleavage reactions of &#8216;cap&#8217; labeled and 3&#8242; labeled S<sub>1</sub>, the amounts of HCV cleavage products were decreased with increased competitor concentration and reached total inhibition at a weight ratio of 1 to 6 PC RNA/HCV RNA for the 5&#8242; end cleavage (<xref ref-type="fig" rid="fig5">Figure 5A</xref>, lane 6) and 1 to 8 for the 3&#8242; end cleavage (<xref ref-type="fig" rid="fig5">Figure 5B</xref>, lane 7). Similar results were obtained using S<sub>2</sub> as a substrate for both sites (data not shown).</p></list-item>
###xml 1555 1574 1551 1570 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Reverse competition</italic>
###xml 1632 1640 1628 1636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Figure 5</xref>
###xml 1794 1796 1790 1792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b24">24</xref>
###xml 1797 1799 1793 1795 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b25">25</xref>
###xml 1850 1852 1842 1844 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 1945 1953 1937 1945 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 2044 2045 2036 2037 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 2156 2165 2148 2157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Figure 5C</xref>
###xml 2234 2235 2226 2227 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1555 2304 1551 2296 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="68"><italic>Reverse competition</italic>. In competition experiments reciprocal to those shown in <xref ref-type="fig" rid="fig5">Figure 5</xref>, we tested the ability of S1 to compete for RNase III activity with a 60-base RNA fragment of the natural substrate, phage T7 early precursor mRNA R1.1 (<xref ref-type="bibr" rid="b24">24</xref>,<xref ref-type="bibr" rid="b25">25</xref>). This fragment was internally labeled with [&#945;<sup>32</sup>P]GTP during transcription from a synthetic DNA template and was used as a substrate for the <italic>in vitro</italic> RNase III cleavage reactions that were competed by increasing concentrations of cold HCV S<sub>1</sub> RNA, from 0.45 to 7.2 nM. About 50% inhibition was reached at a concentration ratio of 1 HCV RNA/T7 R1.1 RNA (<xref ref-type="fig" rid="fig5">Figure 5C</xref>, lane 7). Reverse competition experiments were also performed with S<sub>2</sub> as RNA competitor and we obtained the same results (data not shown).</p>
###xml 1555 2304 1551 2296 <list-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="68"><italic>Reverse competition</italic>. In competition experiments reciprocal to those shown in <xref ref-type="fig" rid="fig5">Figure 5</xref>, we tested the ability of S1 to compete for RNase III activity with a 60-base RNA fragment of the natural substrate, phage T7 early precursor mRNA R1.1 (<xref ref-type="bibr" rid="b24">24</xref>,<xref ref-type="bibr" rid="b25">25</xref>). This fragment was internally labeled with [&#945;<sup>32</sup>P]GTP during transcription from a synthetic DNA template and was used as a substrate for the <italic>in vitro</italic> RNase III cleavage reactions that were competed by increasing concentrations of cold HCV S<sub>1</sub> RNA, from 0.45 to 7.2 nM. About 50% inhibition was reached at a concentration ratio of 1 HCV RNA/T7 R1.1 RNA (<xref ref-type="fig" rid="fig5">Figure 5C</xref>, lane 7). Reverse competition experiments were also performed with S<sub>2</sub> as RNA competitor and we obtained the same results (data not shown).</p></list-item>
###xml 515 2304 511 2296 <list xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" list-type="roman-lower"><list-item><p textid="67"><italic>Competitive inhibition</italic>. This experiment consisted of incubating the same amount of labeled HCV RNA S<sub>1</sub> with increasing concentrations of cold natural dsRNA (from 2- to 12-fold excess) to inhibit HCV RNA cleavages. &#8216;Cap&#8217; labeled or 3&#8242; end-labeled HCV S<sub>1</sub> RNAs were used, respectively, as appropriate to follow the P1 or P3 short product fragments in 14% and 20% polyacrylamide gels. As RNA competitor we employed a dsRNA of substantial length from a virus grown in <italic>Penicillium chrysogenum</italic> (PC RNA) which is a known substrate for <italic>E.coli</italic> RNase III (<xref ref-type="bibr" rid="b30">30</xref>,<xref ref-type="bibr" rid="b31">31</xref>). When this unlabeled (cold) dsRNA, from 20 to 120 ng, was included in the RNase III cleavage reactions of &#8216;cap&#8217; labeled and 3&#8242; labeled S<sub>1</sub>, the amounts of HCV cleavage products were decreased with increased competitor concentration and reached total inhibition at a weight ratio of 1 to 6 PC RNA/HCV RNA for the 5&#8242; end cleavage (<xref ref-type="fig" rid="fig5">Figure 5A</xref>, lane 6) and 1 to 8 for the 3&#8242; end cleavage (<xref ref-type="fig" rid="fig5">Figure 5B</xref>, lane 7). Similar results were obtained using S<sub>2</sub> as a substrate for both sites (data not shown).</p></list-item><list-item><p textid="68"><italic>Reverse competition</italic>. In competition experiments reciprocal to those shown in <xref ref-type="fig" rid="fig5">Figure 5</xref>, we tested the ability of S1 to compete for RNase III activity with a 60-base RNA fragment of the natural substrate, phage T7 early precursor mRNA R1.1 (<xref ref-type="bibr" rid="b24">24</xref>,<xref ref-type="bibr" rid="b25">25</xref>). This fragment was internally labeled with [&#945;<sup>32</sup>P]GTP during transcription from a synthetic DNA template and was used as a substrate for the <italic>in vitro</italic> RNase III cleavage reactions that were competed by increasing concentrations of cold HCV S<sub>1</sub> RNA, from 0.45 to 7.2 nM. About 50% inhibition was reached at a concentration ratio of 1 HCV RNA/T7 R1.1 RNA (<xref ref-type="fig" rid="fig5">Figure 5C</xref>, lane 7). Reverse competition experiments were also performed with S<sub>2</sub> as RNA competitor and we obtained the same results (data not shown).</p></list-item></list>
###xml 606 609 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 709 712 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 760 763 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 977 1000 <span type="species:ncbi:5076">Penicillium chrysogenum</span>
###xml 1041 1047 <span type="species:ncbi:562">E.coli</span>
###xml 1220 1223 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 1361 1364 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 1758 1766 <span type="species:ncbi:10760">phage T7</span>
###xml 2039 2042 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 2135 2138 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
Two additional strategies were used to demonstrate that RNase III, and not a contaminant in the enzyme preparation, was responsible for the processing reaction in S1 and S2 substrates. All competition reactions, direct and reverse, were performed in the presence of an excess high amount (2 microg) of unlabeled tRNA per reaction, which is a large excess over the competitor RNAs involved in the reaction, and eliminates the effects of non-specific inhibition by increasing the total amount of RNA in the reaction. Competitive inhibition. This experiment consisted of incubating the same amount of labeled HCV RNA S1 with increasing concentrations of cold natural dsRNA (from 2- to 12-fold excess) to inhibit HCV RNA cleavages. 'Cap' labeled or 3' end-labeled HCV S1 RNAs were used, respectively, as appropriate to follow the P1 or P3 short product fragments in 14% and 20% polyacrylamide gels. As RNA competitor we employed a dsRNA of substantial length from a virus grown in Penicillium chrysogenum (PC RNA) which is a known substrate for E.coli RNase III (30,31). When this unlabeled (cold) dsRNA, from 20 to 120 ng, was included in the RNase III cleavage reactions of 'cap' labeled and 3' labeled S1, the amounts of HCV cleavage products were decreased with increased competitor concentration and reached total inhibition at a weight ratio of 1 to 6 PC RNA/HCV RNA for the 5' end cleavage (Figure 5A, lane 6) and 1 to 8 for the 3' end cleavage (Figure 5B, lane 7). Similar results were obtained using S2 as a substrate for both sites (data not shown).Reverse competition. In competition experiments reciprocal to those shown in Figure 5, we tested the ability of S1 to compete for RNase III activity with a 60-base RNA fragment of the natural substrate, phage T7 early precursor mRNA R1.1 (24,25). This fragment was internally labeled with [alpha32P]GTP during transcription from a synthetic DNA template and was used as a substrate for the in vitro RNase III cleavage reactions that were competed by increasing concentrations of cold HCV S1 RNA, from 0.45 to 7.2 nM. About 50% inhibition was reached at a concentration ratio of 1 HCV RNA/T7 R1.1 RNA (Figure 5C, lane 7). Reverse competition experiments were also performed with S2 as RNA competitor and we obtained the same results (data not shown).
###end p 66
###begin p 67
###xml 0 22 0 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competitive inhibition</italic>
###xml 100 101 100 101 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 250 251 250 251 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 462 485 462 485 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Penicillium chrysogenum</italic>
###xml 526 532 526 532 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E.coli</italic>
###xml 544 546 544 546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b30">30</xref>
###xml 547 549 547 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b31">31</xref>
###xml 687 688 687 688 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 879 888 879 888 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Figure 5A</xref>
###xml 934 943 934 943 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Figure 5B</xref>
###xml 991 992 991 992 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 91 94 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 194 197 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 245 248 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 462 485 <span type="species:ncbi:5076">Penicillium chrysogenum</span>
###xml 526 532 <span type="species:ncbi:562">E.coli</span>
###xml 705 708 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 846 849 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
Competitive inhibition. This experiment consisted of incubating the same amount of labeled HCV RNA S1 with increasing concentrations of cold natural dsRNA (from 2- to 12-fold excess) to inhibit HCV RNA cleavages. 'Cap' labeled or 3' end-labeled HCV S1 RNAs were used, respectively, as appropriate to follow the P1 or P3 short product fragments in 14% and 20% polyacrylamide gels. As RNA competitor we employed a dsRNA of substantial length from a virus grown in Penicillium chrysogenum (PC RNA) which is a known substrate for E.coli RNase III (30,31). When this unlabeled (cold) dsRNA, from 20 to 120 ng, was included in the RNase III cleavage reactions of 'cap' labeled and 3' labeled S1, the amounts of HCV cleavage products were decreased with increased competitor concentration and reached total inhibition at a weight ratio of 1 to 6 PC RNA/HCV RNA for the 5' end cleavage (Figure 5A, lane 6) and 1 to 8 for the 3' end cleavage (Figure 5B, lane 7). Similar results were obtained using S2 as a substrate for both sites (data not shown).
###end p 67
###begin p 68
###xml 0 19 0 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Reverse competition</italic>
###xml 77 85 77 85 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Figure 5</xref>
###xml 239 241 239 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b24">24</xref>
###xml 242 244 242 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b25">25</xref>
###xml 295 297 291 293 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 390 398 386 394 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 489 490 485 486 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 601 610 597 606 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Figure 5C</xref>
###xml 679 680 675 676 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 203 211 <span type="species:ncbi:10760">phage T7</span>
###xml 484 487 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 580 583 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
Reverse competition. In competition experiments reciprocal to those shown in Figure 5, we tested the ability of S1 to compete for RNase III activity with a 60-base RNA fragment of the natural substrate, phage T7 early precursor mRNA R1.1 (24,25). This fragment was internally labeled with [alpha32P]GTP during transcription from a synthetic DNA template and was used as a substrate for the in vitro RNase III cleavage reactions that were competed by increasing concentrations of cold HCV S1 RNA, from 0.45 to 7.2 nM. About 50% inhibition was reached at a concentration ratio of 1 HCV RNA/T7 R1.1 RNA (Figure 5C, lane 7). Reverse competition experiments were also performed with S2 as RNA competitor and we obtained the same results (data not shown).
###end p 68
###begin title 69
###xml 69 75 69 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E.coli</italic>
###xml 149 151 149 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b19">19</xref>
###xml 152 154 152 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b21">21</xref>
###xml 69 75 <span type="species:ncbi:562">E.coli</span>
###xml 116 119 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
Characterizing the activity of commercial RNase III versus authentic E.coli RNase III on T7 R1.1 mRNA, defining the HCV cleavages as secondary type (19,21)
###end title 69
###begin p 70
###xml 232 241 232 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Figure 5C</xref>
###xml 385 387 385 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b22">22</xref>
###xml 167 170 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
While performing the reverse competition experiments described above, we found that commercial RNAse III from Ambion, in the buffer and salt conditions used to cleave HCV RNA, cleaved the T7 R1.1 RNA producing four migrating bands (Figure 5C), instead of two bands as expected from a single primary cleavage event. Because a secondary cleavage site has also been described in T7 R1.1 (22) we wanted to distinguish if, with the Ambion enzyme preparation and in our salt conditions, we were dealing with the reported secondary RNase III cleavage type, on the one hand; or an ssRNase-specific contaminant in the commercial RNase III preparation or peculiar behavior of the commercial RNase III preparation, on the other hand.
###end p 70
###begin p 71
###xml 333 339 333 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E.coli</italic>
###xml 661 667 661 667 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E.coli</italic>
###xml 756 758 752 754 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 947 948 939 940 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 966 967 958 959 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 969 971 961 963 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b18">18</xref>
###xml 972 974 964 966 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b25">25</xref>
###xml 1062 1064 1054 1056 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b18">18</xref>
###xml 1065 1067 1057 1059 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b21">21</xref>
###xml 1115 1117 1107 1109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b18">18</xref>
###xml 1118 1120 1110 1112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b21">21</xref>
###xml 1185 1193 1177 1185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Figure 6</xref>
###xml 1301 1309 1293 1301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Figure 6</xref>
###xml 593 2268 593 2256 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="72">Enzymes from Ambion, Epicenter, New England Biolabs and the natural <italic>E.coli</italic> RNase III were tested against the R1.1 substrate, transcribed in the presence of [&#945;-<sup>32</sup>P]GTP. All reactions contained 0.5 &#181;l of RNase III enzymes, a large excess of carrier tRNA, RNA substrate and the 'high salt original RNase III buffer&#8212;0.01 M Tris&#8211;HCl, pH 7.6, 0.13 M NH<sub>4</sub>Cl and 0.01 M MgCl<sub>2</sub> (<xref ref-type="bibr" rid="b18">18</xref>,<xref ref-type="bibr" rid="b25">25</xref>). While natural RNase III enzyme preparations&#8212;one from a phosphocellulose column peak (<xref ref-type="bibr" rid="b18">18</xref>,<xref ref-type="bibr" rid="b21">21</xref>) and another from a DEAE&#8211;Sephadex column peak (<xref ref-type="bibr" rid="b18">18</xref>,<xref ref-type="bibr" rid="b21">21</xref>)&#8212;gave two main product bands (corresponding to bands B and E in <xref ref-type="fig" rid="fig6">Figure 6</xref>&#8212;resulting from primary cleavage of R1.1) and two additional faint bands (corresponding to bands C and D in <xref ref-type="fig" rid="fig6">Figure 6</xref>), all three commercial enzymes, including that from Ambion, clearly showed four bands (data not shown). The different pattern was probably due to the fact that the natural RNase III preparations had much lower concentrations than the commercial preparations. This explanation was also supported by the effect of 2 &#181;g of poly(I&#8211;C) dsRNA competitive inhibitor on the reactions, which drastically decreased the activity of the natural enzyme preparation while only slightly affecting the reactions of the much more concentrated commercial enzyme preparations (data not shown). Because the four bands appeared with the authentic RNase III purified without protein fusion techniques in reactions carried out under high salt conditions, because they arise in the presence of excess ssRNA and because their production is inhibited by dsRNA competitor, we can use these results to validate the specificity of commercial enzyme with respect to the natural enzyme.</p>
###xml 593 2268 593 2256 <list-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="72">Enzymes from Ambion, Epicenter, New England Biolabs and the natural <italic>E.coli</italic> RNase III were tested against the R1.1 substrate, transcribed in the presence of [&#945;-<sup>32</sup>P]GTP. All reactions contained 0.5 &#181;l of RNase III enzymes, a large excess of carrier tRNA, RNA substrate and the 'high salt original RNase III buffer&#8212;0.01 M Tris&#8211;HCl, pH 7.6, 0.13 M NH<sub>4</sub>Cl and 0.01 M MgCl<sub>2</sub> (<xref ref-type="bibr" rid="b18">18</xref>,<xref ref-type="bibr" rid="b25">25</xref>). While natural RNase III enzyme preparations&#8212;one from a phosphocellulose column peak (<xref ref-type="bibr" rid="b18">18</xref>,<xref ref-type="bibr" rid="b21">21</xref>) and another from a DEAE&#8211;Sephadex column peak (<xref ref-type="bibr" rid="b18">18</xref>,<xref ref-type="bibr" rid="b21">21</xref>)&#8212;gave two main product bands (corresponding to bands B and E in <xref ref-type="fig" rid="fig6">Figure 6</xref>&#8212;resulting from primary cleavage of R1.1) and two additional faint bands (corresponding to bands C and D in <xref ref-type="fig" rid="fig6">Figure 6</xref>), all three commercial enzymes, including that from Ambion, clearly showed four bands (data not shown). The different pattern was probably due to the fact that the natural RNase III preparations had much lower concentrations than the commercial preparations. This explanation was also supported by the effect of 2 &#181;g of poly(I&#8211;C) dsRNA competitive inhibitor on the reactions, which drastically decreased the activity of the natural enzyme preparation while only slightly affecting the reactions of the much more concentrated commercial enzyme preparations (data not shown). Because the four bands appeared with the authentic RNase III purified without protein fusion techniques in reactions carried out under high salt conditions, because they arise in the presence of excess ssRNA and because their production is inhibited by dsRNA competitor, we can use these results to validate the specificity of commercial enzyme with respect to the natural enzyme.</p></list-item>
###xml 2732 2741 2720 2729 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Figure 6A</xref>
###xml 2958 2966 2946 2954 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Figure 6</xref>
###xml 3397 3399 3385 3387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b21">21</xref>
###xml 2268 3401 2256 3389 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="73">Several changes were made in the reaction conditions to confirm the hypothesis of specific secondary RNase III cleavage in R1.1 RNA. First, Ambion RNase III was used at dilution 1/10 and 1/100, and was compared with the authentic RNase III (DEAE&#8211;sephadex column peak); second, increasing amounts of competitor were used; and third, the high salt buffer conditions were replaced by the buffer and salt conditions used in this work, involving lower monovalent salt (<xref ref-type="fig" rid="fig6">Figure 6A</xref>, 0.05 M versus 0.13 M). It was observed that at the lower enzyme:substrate ratio, bands C and D are only faintly present, and they disappear at once when the dsRNA competitor is added. Significantly, in lanes 5&#8211;2 of <xref ref-type="fig" rid="fig6">Figure 6</xref> this behavior was mimicked by the authentic RNase III enzyme. It is clear that in lane 5, the control reaction with no dsRNA, bands C and D are obviously present; they then disappear as the dsRNA concentration is raised in lanes 4&#8211;2. Thus, the reaction was favored by high enzyme:substrate ratios and by lower salt conditions and is effectively inhibited by dsRNA competitors, as expected for a specific secondary cleavage event (<xref ref-type="bibr" rid="b21">21</xref>).</p>
###xml 2268 3401 2256 3389 <list-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="73">Several changes were made in the reaction conditions to confirm the hypothesis of specific secondary RNase III cleavage in R1.1 RNA. First, Ambion RNase III was used at dilution 1/10 and 1/100, and was compared with the authentic RNase III (DEAE&#8211;sephadex column peak); second, increasing amounts of competitor were used; and third, the high salt buffer conditions were replaced by the buffer and salt conditions used in this work, involving lower monovalent salt (<xref ref-type="fig" rid="fig6">Figure 6A</xref>, 0.05 M versus 0.13 M). It was observed that at the lower enzyme:substrate ratio, bands C and D are only faintly present, and they disappear at once when the dsRNA competitor is added. Significantly, in lanes 5&#8211;2 of <xref ref-type="fig" rid="fig6">Figure 6</xref> this behavior was mimicked by the authentic RNase III enzyme. It is clear that in lane 5, the control reaction with no dsRNA, bands C and D are obviously present; they then disappear as the dsRNA concentration is raised in lanes 4&#8211;2. Thus, the reaction was favored by high enzyme:substrate ratios and by lower salt conditions and is effectively inhibited by dsRNA competitors, as expected for a specific secondary cleavage event (<xref ref-type="bibr" rid="b21">21</xref>).</p></list-item>
###xml 3401 3584 3389 3572 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="74">Fingerprint analysis of the secondary cleavage site of R1.1 RNA using the Ambion enzyme was located within the same T1 fragment product as that of the natural enzyme (data not shown).</p>
###xml 3401 3584 3389 3572 <list-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="74">Fingerprint analysis of the secondary cleavage site of R1.1 RNA using the Ambion enzyme was located within the same T1 fragment product as that of the natural enzyme (data not shown).</p></list-item>
###xml 593 3584 593 3572 <list xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" list-type="roman-lower"><list-item><p textid="72">Enzymes from Ambion, Epicenter, New England Biolabs and the natural <italic>E.coli</italic> RNase III were tested against the R1.1 substrate, transcribed in the presence of [&#945;-<sup>32</sup>P]GTP. All reactions contained 0.5 &#181;l of RNase III enzymes, a large excess of carrier tRNA, RNA substrate and the 'high salt original RNase III buffer&#8212;0.01 M Tris&#8211;HCl, pH 7.6, 0.13 M NH<sub>4</sub>Cl and 0.01 M MgCl<sub>2</sub> (<xref ref-type="bibr" rid="b18">18</xref>,<xref ref-type="bibr" rid="b25">25</xref>). While natural RNase III enzyme preparations&#8212;one from a phosphocellulose column peak (<xref ref-type="bibr" rid="b18">18</xref>,<xref ref-type="bibr" rid="b21">21</xref>) and another from a DEAE&#8211;Sephadex column peak (<xref ref-type="bibr" rid="b18">18</xref>,<xref ref-type="bibr" rid="b21">21</xref>)&#8212;gave two main product bands (corresponding to bands B and E in <xref ref-type="fig" rid="fig6">Figure 6</xref>&#8212;resulting from primary cleavage of R1.1) and two additional faint bands (corresponding to bands C and D in <xref ref-type="fig" rid="fig6">Figure 6</xref>), all three commercial enzymes, including that from Ambion, clearly showed four bands (data not shown). The different pattern was probably due to the fact that the natural RNase III preparations had much lower concentrations than the commercial preparations. This explanation was also supported by the effect of 2 &#181;g of poly(I&#8211;C) dsRNA competitive inhibitor on the reactions, which drastically decreased the activity of the natural enzyme preparation while only slightly affecting the reactions of the much more concentrated commercial enzyme preparations (data not shown). Because the four bands appeared with the authentic RNase III purified without protein fusion techniques in reactions carried out under high salt conditions, because they arise in the presence of excess ssRNA and because their production is inhibited by dsRNA competitor, we can use these results to validate the specificity of commercial enzyme with respect to the natural enzyme.</p></list-item><list-item><p textid="73">Several changes were made in the reaction conditions to confirm the hypothesis of specific secondary RNase III cleavage in R1.1 RNA. First, Ambion RNase III was used at dilution 1/10 and 1/100, and was compared with the authentic RNase III (DEAE&#8211;sephadex column peak); second, increasing amounts of competitor were used; and third, the high salt buffer conditions were replaced by the buffer and salt conditions used in this work, involving lower monovalent salt (<xref ref-type="fig" rid="fig6">Figure 6A</xref>, 0.05 M versus 0.13 M). It was observed that at the lower enzyme:substrate ratio, bands C and D are only faintly present, and they disappear at once when the dsRNA competitor is added. Significantly, in lanes 5&#8211;2 of <xref ref-type="fig" rid="fig6">Figure 6</xref> this behavior was mimicked by the authentic RNase III enzyme. It is clear that in lane 5, the control reaction with no dsRNA, bands C and D are obviously present; they then disappear as the dsRNA concentration is raised in lanes 4&#8211;2. Thus, the reaction was favored by high enzyme:substrate ratios and by lower salt conditions and is effectively inhibited by dsRNA competitors, as expected for a specific secondary cleavage event (<xref ref-type="bibr" rid="b21">21</xref>).</p></list-item><list-item><p textid="74">Fingerprint analysis of the secondary cleavage site of R1.1 RNA using the Ambion enzyme was located within the same T1 fragment product as that of the natural enzyme (data not shown).</p></list-item></list>
###xml 333 339 <span type="species:ncbi:562">E.coli</span>
###xml 661 667 <span type="species:ncbi:562">E.coli</span>
A series of experiments were performed to distinguish among these alternatives. We used the T7 R1.1 RNA substrate to characterize (i) the activity of the recombinant enzyme from Ambion, as well as RNase III preparations from two other companies, in buffer conditions of the standard RNase III reaction and in comparison with natural E.coli enzyme; (ii) the activity of the Ambion enzyme on R1.1 RNA substrate in the buffer and salt conditions used in this paper, taking also as reference the authentic RNase III preparation; and (iii) the secondary cleavage site of the Ambion enzyme in R1.1. Enzymes from Ambion, Epicenter, New England Biolabs and the natural E.coli RNase III were tested against the R1.1 substrate, transcribed in the presence of [alpha-32P]GTP. All reactions contained 0.5 microl of RNase III enzymes, a large excess of carrier tRNA, RNA substrate and the 'high salt original RNase III buffer-0.01 M Tris-HCl, pH 7.6, 0.13 M NH4Cl and 0.01 M MgCl2 (18,25). While natural RNase III enzyme preparations-one from a phosphocellulose column peak (18,21) and another from a DEAE-Sephadex column peak (18,21)-gave two main product bands (corresponding to bands B and E in Figure 6-resulting from primary cleavage of R1.1) and two additional faint bands (corresponding to bands C and D in Figure 6), all three commercial enzymes, including that from Ambion, clearly showed four bands (data not shown). The different pattern was probably due to the fact that the natural RNase III preparations had much lower concentrations than the commercial preparations. This explanation was also supported by the effect of 2 microg of poly(I-C) dsRNA competitive inhibitor on the reactions, which drastically decreased the activity of the natural enzyme preparation while only slightly affecting the reactions of the much more concentrated commercial enzyme preparations (data not shown). Because the four bands appeared with the authentic RNase III purified without protein fusion techniques in reactions carried out under high salt conditions, because they arise in the presence of excess ssRNA and because their production is inhibited by dsRNA competitor, we can use these results to validate the specificity of commercial enzyme with respect to the natural enzyme.Several changes were made in the reaction conditions to confirm the hypothesis of specific secondary RNase III cleavage in R1.1 RNA. First, Ambion RNase III was used at dilution 1/10 and 1/100, and was compared with the authentic RNase III (DEAE-sephadex column peak); second, increasing amounts of competitor were used; and third, the high salt buffer conditions were replaced by the buffer and salt conditions used in this work, involving lower monovalent salt (Figure 6A, 0.05 M versus 0.13 M). It was observed that at the lower enzyme:substrate ratio, bands C and D are only faintly present, and they disappear at once when the dsRNA competitor is added. Significantly, in lanes 5-2 of Figure 6 this behavior was mimicked by the authentic RNase III enzyme. It is clear that in lane 5, the control reaction with no dsRNA, bands C and D are obviously present; they then disappear as the dsRNA concentration is raised in lanes 4-2. Thus, the reaction was favored by high enzyme:substrate ratios and by lower salt conditions and is effectively inhibited by dsRNA competitors, as expected for a specific secondary cleavage event (21).Fingerprint analysis of the secondary cleavage site of R1.1 RNA using the Ambion enzyme was located within the same T1 fragment product as that of the natural enzyme (data not shown).
###end p 71
###begin p 72
###xml 68 74 68 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E.coli</italic>
###xml 163 165 159 161 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 354 355 346 347 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 373 374 365 366 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 376 378 368 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b18">18</xref>
###xml 379 381 371 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b25">25</xref>
###xml 469 471 461 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b18">18</xref>
###xml 472 474 464 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b21">21</xref>
###xml 522 524 514 516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b18">18</xref>
###xml 525 527 517 519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b21">21</xref>
###xml 592 600 584 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Figure 6</xref>
###xml 708 716 700 708 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Figure 6</xref>
###xml 68 74 <span type="species:ncbi:562">E.coli</span>
Enzymes from Ambion, Epicenter, New England Biolabs and the natural E.coli RNase III were tested against the R1.1 substrate, transcribed in the presence of [alpha-32P]GTP. All reactions contained 0.5 microl of RNase III enzymes, a large excess of carrier tRNA, RNA substrate and the 'high salt original RNase III buffer-0.01 M Tris-HCl, pH 7.6, 0.13 M NH4Cl and 0.01 M MgCl2 (18,25). While natural RNase III enzyme preparations-one from a phosphocellulose column peak (18,21) and another from a DEAE-Sephadex column peak (18,21)-gave two main product bands (corresponding to bands B and E in Figure 6-resulting from primary cleavage of R1.1) and two additional faint bands (corresponding to bands C and D in Figure 6), all three commercial enzymes, including that from Ambion, clearly showed four bands (data not shown). The different pattern was probably due to the fact that the natural RNase III preparations had much lower concentrations than the commercial preparations. This explanation was also supported by the effect of 2 microg of poly(I-C) dsRNA competitive inhibitor on the reactions, which drastically decreased the activity of the natural enzyme preparation while only slightly affecting the reactions of the much more concentrated commercial enzyme preparations (data not shown). Because the four bands appeared with the authentic RNase III purified without protein fusion techniques in reactions carried out under high salt conditions, because they arise in the presence of excess ssRNA and because their production is inhibited by dsRNA competitor, we can use these results to validate the specificity of commercial enzyme with respect to the natural enzyme.
###end p 72
###begin p 73
###xml 464 473 464 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Figure 6A</xref>
###xml 690 698 690 698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Figure 6</xref>
###xml 1129 1131 1129 1131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b21">21</xref>
Several changes were made in the reaction conditions to confirm the hypothesis of specific secondary RNase III cleavage in R1.1 RNA. First, Ambion RNase III was used at dilution 1/10 and 1/100, and was compared with the authentic RNase III (DEAE-sephadex column peak); second, increasing amounts of competitor were used; and third, the high salt buffer conditions were replaced by the buffer and salt conditions used in this work, involving lower monovalent salt (Figure 6A, 0.05 M versus 0.13 M). It was observed that at the lower enzyme:substrate ratio, bands C and D are only faintly present, and they disappear at once when the dsRNA competitor is added. Significantly, in lanes 5-2 of Figure 6 this behavior was mimicked by the authentic RNase III enzyme. It is clear that in lane 5, the control reaction with no dsRNA, bands C and D are obviously present; they then disappear as the dsRNA concentration is raised in lanes 4-2. Thus, the reaction was favored by high enzyme:substrate ratios and by lower salt conditions and is effectively inhibited by dsRNA competitors, as expected for a specific secondary cleavage event (21).
###end p 73
###begin p 74
Fingerprint analysis of the secondary cleavage site of R1.1 RNA using the Ambion enzyme was located within the same T1 fragment product as that of the natural enzyme (data not shown).
###end p 74
###begin title 75
###xml 31 34 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
Cleavage sequences surrounding HCV 5' and 3' cleavages reside in a single RNA structural motif with double-stranded character
###end title 75
###begin p 76
###xml 305 306 305 306 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 406 414 406 414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1</xref>
###xml 513 514 513 514 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 808 809 808 809 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 53 56 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
The two sequences surrounding both cleavage sites in HCV RNA contain a high degree of complementarity. If both cleavage sites participate in a single RNA motif with double-stranded characteristics, deletion of one of the two complementary sequences should also prevent cleavage in the other. We prepared S3 substrate, which spanned bases 1-402 and lacked the sequence that comprises 3' the cleavable site (Figure 1). After RNase III incubation, a set of very faint bands migrating closely together and below the S3 substrate appeared in the gel electrophoresis, but the appearance of these bands is not RNase III dependent as their presence was not affected by incubation with dsRNA. In addition, this 402-base substrate was unable to compete with T7 R.1.1 RNA cleavage by RNase III (data not shown). Thus, S3 substrate has lost the RNA structure that provides sensitivity to RNase III at the 5'-proximal site.
###end p 76
###begin p 77
###xml 344 345 344 345 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 615 623 609 617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Figure 7</xref>
###xml 1215 1223 1209 1217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig8">Figure 8</xref>
###xml 278 281 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 1205 1208 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
In a second type experiment, a ribo-oligonucleotide complementary to positions 23-43 (5'-rGGAGUCAUGUAUGGCGGAGUC-3'), within which the 5' cleavage site is located, was hybridized in excess concentration (15 nM) to block the hypothetical downstream Watson-Crick binding region in HCV RNA substrates (0.6 nM) containing the 3' end cleavage site. S1 substrate was pre-heated in the absence or presence of the ribo-oligonucleotide, buffer added, and the reactions cooled to 37degreesC, when the RNase III enzyme was added. Aliquots were obtained during the time course of the reaction and run on polyacrylamide gels. In Figure 7, it may be observed that in the presence (+) of the complementary ribo-oligonucleotide the band pattern of the products changed with respect to those incubated without the ribo-oligonucleotide (-). Specifically, a different pattern appeared, consistent with RNase III cleavage directed solely by the ribo-oligonucleotide. This proved that blocking the 5' sequence motif impedes the formation of the RNA structure required for cleavage at the 3' end. Together, the two experiments represent direct proof of the interaction between sequences containing both cleavages, enclosing the HCV IRES (Figure 8).
###end p 77
###begin title 78
DISCUSSION
###end title 78
###begin p 79
###xml 52 58 52 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E.coli</italic>
###xml 262 271 262 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figures 1</xref>
###xml 272 273 272 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">3</xref>
###xml 483 485 471 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b34">34</xref>
###xml 666 675 654 663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figures 4</xref>
###xml 676 677 664 665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">6</xref>
###xml 821 829 809 817 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Figure 6</xref>
###xml 52 58 <span type="species:ncbi:562">E.coli</span>
###xml 149 152 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 326 329 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 738 741 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
Here, we have provided evidence that RNase III from E.coli cleaves specifically and with high efficiency at sites within two sequence domains in the HCV IRES, which we have mapped to one region containing bases 27 and 33, and another region containing base 439 (Figures 1-3). The first region is immediately upstream from the HCV IRES domain, while the other is approximately70 bases downstream [assuming that the IRES includes 30 nt of sequence downstream from the AUG start codon (34)]. Furthermore, we have confirmed by end group determination and substrate competition experiments that both natural and commercial RNase III preparations carry out this reaction (Figures 4-6). In addition, we have shown by several criteria that these HCV cleavages by RNase III fall into the category of specific secondary cleavages (Figure 6).
###end p 79
###begin p 80
###xml 110 118 110 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Figure 7</xref>
###xml 238 246 238 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig8">Figure 8</xref>
###xml 356 364 356 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Figure 7</xref>
###xml 630 638 630 638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Figure 7</xref>
###xml 58 61 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 806 809 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 885 888 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
Because cleavage within one RNase III-sensitive region of HCV requires coordinated cleavage within the other (Figure 7), we propose that the two widely separated sequence elements which comprise them in fact form a base-paired structure (Figure 8), which is present at sufficient frequency to allow over 80% of the substrate to undergo RNase III cleavage (Figure 7). This conclusion is supported by the fact that 5'-proximal RNase III cleavage fails to occur in the absence of the 3'-proximal sequence (data not shown), and 3' cleavage is blocked when the 5' cleavable region is hybridized to a complementary RNA oligonucleotide (Figure 7). We will briefly address how these findings relate to other RNase III-specific reactions; how the structured element identified here relates to previously identified HCV IRES structures and how a dsRNA structure bracketing the IRES might affect HCV gene expression.
###end p 80
###begin p 81
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E.coli</italic>
###xml 56 58 56 58 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b19">19</xref>
###xml 0 6 <span type="species:ncbi:562">E.coli</span>
E.coli RNase III carries out three principal reactions (19): the digestion of perfect dsRNA to 15 bp fragments, independent of sequence; primary cleavage, usually of imperfectly base-paired regions which have evolved to play a role in host rRNA processing; and secondary cleavage, in which imperfectly base-paired regions from other RNAs, which resemble primary RNase III sites, are cleaved. While both dsRNA digestion and primary cleavage by RNase III are optimized in higher (>0.1 M monovalent cation) salt and lower enzyme:substrate conditions, secondary cleavage is favored at lower salt and higher enzyme:substrate ratios.
###end p 81
###begin p 82
###xml 272 274 272 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b35">35</xref>
###xml 289 291 289 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b36">36</xref>
###xml 325 327 325 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b37">37</xref>
###xml 328 330 328 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b38">38</xref>
###xml 360 362 360 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b36">36</xref>
###xml 100 103 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 260 270 <span type="species:ncbi:138953">poliovirus</span>
###xml 297 323 <span type="species:ncbi:11276">vesicular stomatitis virus</span>
Cleavage sites sensitive to RNase III under low salt conditions, such as the ones described here in HCV RNA, have been reported in earlier studies on RNase III. In particular, RNase III cleavage of the genomic RNAs of several eukaryotic RNA viruses, including poliovirus (35), adenovirus (36) and vesicular stomatitis virus (37,38), as well as mammalian rRNA (36), have been reported. However, these earlier findings neither did lead to a general explanation for the presence of such RNase III sites, nor did they give rise to further research, in contrast to the situation with prokaryotic RNase III sites. This lack of follow-up probably took place because mammalian RNase III-like enzymes had not yet been discovered; and because the earlier eukaryotic RNase III signals were not mapped to the base their exact RNA structure could not be ascertained.
###end p 82
###begin p 83
###xml 127 128 127 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b1">1</xref>
###xml 129 130 129 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b4">4</xref>
###xml 186 188 186 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b39">39</xref>
###xml 214 216 214 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b40">40</xref>
###xml 505 507 505 507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b26">26</xref>
###xml 508 510 508 510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b41">41</xref>
###xml 577 578 577 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b1">1</xref>
###xml 579 581 579 581 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b26">26</xref>
###xml 582 584 582 584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b41">41</xref>
###xml 53 56 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 490 495 <span type="species:ncbi:9606">human</span>
Previously identified RNA structural elements in the HCV IRES include a pseudoknot just upstream from the AUG initiator codon (1-4), a UV-crosslinkable tertiary element in stem-loop II (39), two E-loop structures (40), one in the upper part of stem-loop II and the other in stem-loop IIId, a domain which undergoes UV-activated self-cleavage near the top of stem-loop II (A. J. Lyons and H. D. Robertson, manuscript submitted) and a tRNA-like element near the AUG start codon recognized by human RNase P (26,41). While functions have been suggested for some of these elements (1,26,41) others still await assignment. The presence of such elements in the near vicinity of a structural domain capable of undergoing RNase III cleavage requires further consideration.
###end p 83
###begin p 84
###xml 319 327 319 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig8">Figure 8</xref>
###xml 417 419 417 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b15">15</xref>
###xml 420 422 420 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b42">42</xref>
###xml 423 425 423 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b43">43</xref>
###xml 658 660 658 660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b26">26</xref>
###xml 661 663 661 663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b41">41</xref>
###xml 664 666 664 666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b44">44</xref>
###xml 757 758 757 758 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b1">1</xref>
###xml 759 761 759 761 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b45">45</xref>
###xml 762 764 762 764 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b46">46</xref>
###xml 62 65 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 563 566 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 584 589 <span type="species:ncbi:9606">human</span>
###xml 841 844 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
First, there are a growing number of similarities between the HCV IRES and the adjacent core protein coding sequence, especially the first 1/3 thereof. Our data show that an RNAse III-sensitive structure converts the 5'-UTR and 1/3 of the core-coding region into a circular RNA loop, closed by base pairing as shown in Figure 8. The IRES and core-coding regions, in addition to sharing a highly structured character (15,42,43), overlap in several other ways. First, the IRES contains the first 30 bases of the core-coding sequence. Second, sequences required for HCV IRES cleavage by human RNase P may include bases at or near the IRES/core-coding junction (26,41,44). In addition, the IRES and core-coding regions share a low degree of sequence variation (1,45,46). Together, these findings suggest that the two domains in this part of the HCV genome may have a structural and evolutionary unity, despite the coding/non-coding discontinuity, an idea which is strengthened by our finding that each domain contributes one of the two required elements which form the RNase III-sensitive structure whose discovery we report here.
###end p 84
###begin p 85
###xml 215 217 215 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b47">47</xref>
###xml 343 345 343 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b48">48</xref>
###xml 466 468 466 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b39">39</xref>
###xml 469 471 469 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b49">49</xref>
###xml 547 548 547 548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b1">1</xref>
###xml 549 551 549 551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b48">48</xref>
###xml 24 45 <span type="species:ncbi:12475">hepatitis delta virus</span>
###xml 47 50 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
###xml 273 276 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
###xml 325 328 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 353 356 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
###xml 365 368 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 479 482 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 487 490 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
###xml 638 643 <span type="species:ncbi:9606">human</span>
The circular RNA of the hepatitis delta virus (HDV) is also an RNA circle (closed covalently rather by hydrogen bonds) which contains highly structured non-coding and coding regions that are adjacent to each other (47). Furthermore, the 'delta antigen' protein, encoded by HDV RNA, is a nucleic acid binding protein like the HCV core protein (48). Both HDV and the HCV IRES region also contain a motif highly sensitive to UV irradiation in their non-coding regions (39,49). Both HCV and HDV also infect the liver to provoke consistent infections (1,48) and could reflect the evolution of a common unit of RNA expression pathogenic to the human liver.
###end p 85
###begin p 86
###xml 96 98 96 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b44">44</xref>
###xml 344 350 344 350 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E.coli</italic>
###xml 439 441 439 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b36">36</xref>
###xml 442 444 442 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b50">50</xref>
###xml 445 447 445 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b53">53</xref>
###xml 482 484 482 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b54">54</xref>
###xml 507 514 507 514 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 4 7 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 344 350 <span type="species:ncbi:562">E.coli</span>
###xml 475 480 <span type="species:ncbi:4932">yeast</span>
###xml 584 587 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
The HCV RNase III signal maps within 79 and 130 bases of a previously described RNase P signal (44). With regard to the presence of tRNA-like structure which stimulates RNase P cleavage in the near vicinity of RNase III cleavage sites, there are several noteworthy examples where these two kinds of signals appear close together, including the E.coli rRNA precursor molecule, the 10sa RNA molecule, and the mRNA of several bacteriophages (36,50-53) and in structural RNAs in yeast (54). The significance to in vivo function of both of these signal types remains to be established for HCV, although in the other cases mentioned both types participate in a common RNA processing pathway.
###end p 86
###begin p 87
###xml 335 340 335 340 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 343 345 343 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b16">16</xref>
###xml 735 743 735 743 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1062 1064 1062 1064 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b55">55</xref>
###xml 1065 1067 1065 1067 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b56">56</xref>
###xml 1282 1291 1282 1291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Figure 7B</xref>
###xml 50 53 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 302 305 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 547 550 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 720 723 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 818 821 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 965 968 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 1142 1145 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
The presence of a structural element flanking the HCV IRES raises questions about how it may affect IRES activity. The most direct role would be in regulating the access of ribosomes to the IRES start signal. In their study of phylogenetic and mutational data favoring some type of interaction between HCV bases 24-38 and 428-442, Kim et al. (16) suggested that such an element might inhibit translation. Further studies will be required to measure the ability of IRES-specific components (initiation factors, ribosomal subunits, RNase P) to bind HCV RNA with versus without the RNase III-sensitive structure. It is interesting to note, in this regard, that the vast majority of studies on translation stimulated by the HCV IRES, both in vitro and in cells and using either mono- or di-cistronic constructs, have used HCV IRES sequences spanning only bases 1-400, lacking the RNase III-sensitive structure. Several studies on ribosome binding and translation of an HCV mRNA spanning bases 1-1350 (which contains the RNase III-sensitive structure) are available (55,56), but a systematic comparison of protein synthesis stimulated by the same HCV mRNA molecule, with and without the RNase III-sensitive structure (which can be blocked by cleavage or by oligonucleotides, as shown in Figure 7B), is yet to be performed. Such studies will be necessary to determine whether the RNase III-sensitive structure promotes or inhibits ribosome binding and translation, or has no effect.
###end p 87
###begin p 88
###xml 519 521 519 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b15">15</xref>
###xml 522 524 522 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b43">43</xref>
###xml 14 17 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 355 358 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 682 685 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
The 5'-UTR of HCV genomic RNA encodes the start signal for genomic strand RNA synthesis (which is the 3' end of the antigenomic, or minus, strand), as well as the IRES itself, suggesting a role for some of these sequences in both processes. One of the difficulties concerning a structure containing the two domains studied here-one near the 5' end of the HCV UTR involving bases 24-38, the other including bases 428-442-was that earlier work had suggested a structure called stem-loop VI within the core-coding domain (15,43), in which bases 428-442 are base paired with bases 495-508. In fact, the ability of these two potential structures to alternate could regulate a particular HCV RNA molecule's ability to participate in translation versus replication. Experiments comparing the stability of the proposed stem-loop VI to the RNase III-sensitive structural element studied here will need to be performed before this idea can be evaluated.
###end p 88
###begin p 89
The conditions described here allow reproducible, structure-dependent cleavage reactions which can produce specific RNA fragments for a variety of assays. For example, binding of translation initiation factors, La protein, PKR and ribosomal proteins could be conducted before and after RNase III treatment. In this way, both the boundaries of the IRES domain, and its structural inter-dependence with the flanking, RNase III-sensitive sequences, can be ascertained. Whatever the role of the RNase-sensitive structure, it allows new basic studies on IRES structure and function, and provides opportunities for RNAi and ribozyme therapeutics as well.
###end p 89
###begin title 90
NOTE ADDED IN PROOF
###end title 90
###begin p 91
Dr Hugh D. Robertson, our friend and co-author of this paper died August 22, 2005.
###end p 91
###begin p 92
###xml 243 248 <span type="species:ncbi:2708">Lemon</span>
The authors thank Tsering Choden and Drs Maria Piron, Anna Nadal, Rosario Sabariegos, Isabel Leal and Javier Martinez for their enthusiastic scientific support. Plasmidic vector pN (1-4728) Bluescript was kindly provided by M. Honda and S. M. Lemon, and plasmid DNA template for RNA R1.1 transcripts was supplied by Dr A. Nicholson. This work was supported by a grant from the US NIH and by a Johnson & Johnson Focused Giving award to H.D.R., and by Ministerio de Ciencia y Tecnologia Grant BIO-04-06114 and foundation FIPSE, grant number 36293/02 to J.G. Funding to pay the Open Access publication charges for this article was provided by Ministerio de Ciencia Tecnologia Grant BIO-04-06114.
###end p 92
###begin p 93
###xml 0 30 0 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Conflict of interest statement</italic>
Conflict of interest statement. None declared.
###end p 93
###begin title 94
REFERENCES
###end title 94
###begin article-title 95
###xml 0 17 <span type="species:ncbi:11103">Hepatitis C virus</span>
Hepatitis C virus
###end article-title 95
###begin article-title 96
###xml 36 53 <span type="species:ncbi:11103">hepatitis C virus</span>
Internal ribosome entry site within hepatitis C virus RNA
###end article-title 96
###begin article-title 97
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
###xml 115 132 <span type="species:ncbi:12092">hepatitis A virus</span>
###xml 166 192 <span type="species:ncbi:12104">encephalomyocarditis virus</span>
In vitro characterization of an internal ribosomal entry site (IRES) present within the 5' nontranslated region of hepatitis A virus RNA: comparison with the IRES of encephalomyocarditis virus
###end article-title 97
###begin article-title 98
###xml 83 100 <span type="species:ncbi:11103">hepatitis C virus</span>
A conserved helical element is essential for internal initiation of translation of hepatitis C virus RNA
###end article-title 98
###begin article-title 99
###xml 112 129 <span type="species:ncbi:11103">hepatitis C virus</span>
Role of the 5'-proximal stem-loop structure of the 5' untranslated region in the replication and translation of hepatitis C virus RNA
###end article-title 99
###begin article-title 100
###xml 26 43 <span type="species:ncbi:11103">hepatitis C virus</span>
Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line [see comments]
###end article-title 100
###begin article-title 101
###xml 24 27 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
Efficient initiation of HCV RNA replication in cell culture
###end article-title 101
###begin article-title 102
###xml 118 135 <span type="species:ncbi:11103">hepatitis C virus</span>
Stability of a stem-loop involving the initiator AUG controls the efficiency of internal initiation of translation on hepatitis C virus RNA
###end article-title 102
###begin article-title 103
###xml 102 119 <span type="species:ncbi:11103">hepatitis C virus</span>
Structural requirements for initiation of translation by internal ribosome entry within genome-length hepatitis C virus RNA
###end article-title 103
###begin article-title 104
###xml 54 71 <span type="species:ncbi:11103">hepatitis C virus</span>
Mutational analysis of the different bulge regions of hepatitis C virus domain II and their influence on internal ribosome entry site translational activity
###end article-title 104
###begin article-title 105
###xml 38 55 <span type="species:ncbi:11103">hepatitis C virus</span>
Internal initiation of translation of hepatitis C virus RNA: the ribosome entry site is at the authentic initiation codon
###end article-title 105
###begin article-title 106
###xml 49 66 <span type="species:ncbi:11103">hepatitis C virus</span>
Sequence analysis of the 5' non-coding region of hepatitis C virus
###end article-title 106
###begin article-title 107
###xml 17 34 <span type="species:ncbi:11103">hepatitis C virus</span>
###xml 141 144 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
Variation of the hepatitis C virus 5' non-coding region: implications for secondary structure, virus detection and typing. The International HCV Collaborative Study Group
###end article-title 107
###begin article-title 108
###xml 59 70 <span type="species:ncbi:11103">hepatitis C</span>
###xml 114 122 <span type="species:ncbi:9606">patients</span>
Internal initiation of translation efficiency in different hepatitis C genotypes isolated from interferon treated patients
###end article-title 108
###begin article-title 109
###xml 78 95 <span type="species:ncbi:11103">hepatitis C virus</span>
Natural variation in translational activities of the 5' nontranslated RNAs of hepatitis C virus genotypes 1a and 1b: evidence for a long-range RNA-RNA interaction outside of the internal ribosomal entry site
###end article-title 109
###begin article-title 110
###xml 100 117 <span type="species:ncbi:11103">hepatitis C virus</span>
Long-range RNA-RNA interaction between the 5' nontranslated region and the core-coding sequences of hepatitis C virus modulates the IRES-dependent translation
###end article-title 110
###begin article-title 111
A nuclease specific for double-stranded RNA
###end article-title 111
###begin article-title 112
###xml 53 69 53 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 53 69 <span type="species:ncbi:562">Escherichia coli</span>
Purification and properties of ribonuclease III from Escherichia coli
###end article-title 112
###begin article-title 113
###xml 0 16 0 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 0 16 <span type="species:ncbi:562">Escherichia coli</span>
Escherichia coli ribonuclease III cleavage sites
###end article-title 113
###begin article-title 114
The ribonuclease III superfamily: forms and functions in RNA maturation, decay, and gene silencing
###end article-title 114
###begin article-title 115
RNase III cleavage of single-stranded RNA. Effect of ionic strength on the fidelity of cleavage
###end article-title 115
###begin article-title 116
###xml 31 47 <span type="species:ncbi:10760">bacteriophage T7</span>
Ribonuclease III cleavage of a bacteriophage T7 processing signal. Divalent cation specificity, and specific anion effects
###end article-title 116
###begin article-title 117
###xml 65 81 <span type="species:ncbi:10760">bacteriophage T7</span>
A nucleotide sequence from a ribonuclease III processing site in bacteriophage T7 RNA
###end article-title 117
###begin article-title 118
###xml 32 48 <span type="species:ncbi:10760">bacteriophage T7</span>
Complete nucleotide sequence of bacteriophage T7 DNA and the locations of T7 genetic elements
###end article-title 118
###begin article-title 119
###xml 0 16 0 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 0 16 <span type="species:ncbi:562">Escherichia coli</span>
Escherichia coli Ribonuclease III
###end article-title 119
###begin article-title 120
###xml 21 38 <span type="species:ncbi:11103">hepatitis C virus</span>
###xml 53 58 <span type="species:ncbi:9606">human</span>
Specific cleavage of hepatitis C virus RNA genome by human RNase P
###end article-title 120
###begin article-title 121
###xml 49 54 49 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 92 108 92 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 113 130 113 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bacillus subtilis</italic>
###xml 92 108 <span type="species:ncbi:562">Escherichia coli</span>
###xml 113 130 <span type="species:ncbi:1423">Bacillus subtilis</span>
Exploring the minimal substrate requirements for trans-cleavage by RNase P holoenzymes from Escherichia coli and Bacillus subtilis
###end article-title 121
###begin article-title 122
RNA fingerprinting
###end article-title 122
###begin article-title 123
###xml 70 86 70 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 70 86 <span type="species:ncbi:562">Escherichia coli</span>
RNase III cleavage is obligate for maturation but not for function of Escherichia coli pre-23S rRNA
###end article-title 123
###begin article-title 124
###xml 45 61 45 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 45 61 <span type="species:ncbi:562">Escherichia coli</span>
Cleavage of T4 species I ribonucleic acid by Escherichia coli ribonuclease III
###end article-title 124
###begin article-title 125
###xml 40 56 40 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 40 56 <span type="species:ncbi:562">Escherichia coli</span>
Ribonucleic acid processing activity of Escherichia coli ribonuclease III
###end article-title 125
###begin article-title 126
Degradation of nucleic acids
###end article-title 126
###begin article-title 127
###xml 42 58 42 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 42 58 <span type="species:ncbi:562">Escherichia coli</span>
Purification and properties of a specific Escherichia coli ribonuclease which cleaves a tyrosine transfer ribonucleic acid precursor
###end article-title 127
###begin article-title 128
The influence of viral coding sequences on pestivirus IRES activity reveals further parallels with translation initiation in prokaryotes
###end article-title 128
###begin article-title 129
###xml 62 72 <span type="species:ncbi:138953">poliovirus</span>
Identification of specific fragments containing the 5' end of poliovirus RNA after ribonuclease III digestion
###end article-title 129
###begin article-title 130
Cleavage of adenovirus messenger RNA and of 28S and 18S ribosomal RNA by RNase III
###end article-title 130
###begin article-title 131
###xml 18 44 <span type="species:ncbi:11276">vesicular stomatitis virus</span>
RNase III cleaves vesicular stomatitis virus genome-length RNAs but fails to cleave viral mRNA's
###end article-title 131
###begin article-title 132
Characterization and mapping of RNase III cleavage sites in VSV genome RNA
###end article-title 132
###begin article-title 133
###xml 0 17 <span type="species:ncbi:11103">Hepatitis C virus</span>
Hepatitis C virus internal ribosome entry site RNA contains a tertiary structural element in a functional domain of stem-loop II
###end article-title 133
###begin article-title 134
###xml 13 16 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
Structure of HCV IRES domain II determined by NMR
###end article-title 134
###begin article-title 135
Detection of tRNA-like structure through RNase P cleavage of viral internal ribosome entry site RNAs near the AUG start triplet
###end article-title 135
###begin article-title 136
###xml 23 34 <span type="species:ncbi:11103">hepatitis C</span>
Structural analysis of hepatitis C RNA genome using DNA microarrays
###end article-title 136
###begin article-title 137
###xml 46 63 <span type="species:ncbi:11103">hepatitis C virus</span>
Mutation Master: profiles of substitutions in hepatitis C virus RNA of the core, alternate reading frame, and NS2 coding regions
###end article-title 137
###begin article-title 138
###xml 93 110 <span type="species:ncbi:11103">hepatitis C virus</span>
Characterizing the function and structural organization of the 5' tRNA-like motif within the hepatitis C virus quasispecies
###end article-title 138
###begin article-title 139
###xml 48 65 <span type="species:ncbi:11103">hepatitis C virus</span>
Sequence analysis of the 5' noncoding region of hepatitis C virus
###end article-title 139
###begin article-title 140
###xml 41 58 <span type="species:ncbi:11103">hepatitis C virus</span>
Sequence analysis of the core gene of 14 hepatitis C virus genotypes
###end article-title 140
###begin article-title 141
How did replicating and coding RNAs first get together?
###end article-title 141
###begin article-title 142
###xml 0 21 <span type="species:ncbi:12475">Hepatitis delta virus</span>
Hepatitis delta virus
###end article-title 142
###begin article-title 143
###xml 79 100 <span type="species:ncbi:12475">hepatitis delta virus</span>
An ultraviolet-sensitive RNA structural element in a viroid-like domain of the hepatitis delta virus
###end article-title 143
###begin article-title 144
10Sa RNA: processing by and inhibition of RNase III
###end article-title 144
###begin article-title 145
Ribonuclease P: unity and diversity in a tRNA processing ribozyme
###end article-title 145
###begin article-title 146
T7 early RNAs are generated by site-specific cleavages
###end article-title 146
###begin article-title 147
###xml 18 34 18 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 84 91 84 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 18 34 <span type="species:ncbi:562">Escherichia coli</span>
T7 early RNAs and Escherichia coli ribosomal RNAs are cut from large precursor RNAs in vivo by ribonuclease 3
###end article-title 147
###begin article-title 148
RNA Processing
###end article-title 148
###begin article-title 149
###xml 29 46 <span type="species:ncbi:11103">hepatitis C virus</span>
The ribosome binding site of hepatitis C virus mRNA
###end article-title 149
###begin article-title 150
###xml 15 32 <span type="species:ncbi:11103">hepatitis C virus</span>
Domains on the hepatitis C virus internal ribosome entry site for 40s subunit binding
###end article-title 150
###begin title 151
Figures and Tables
###end title 151
###begin p 152
###xml 259 260 259 260 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 271 272 271 272 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 283 284 283 284 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 329 335 329 335 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E.coli</italic>
###xml 20 23 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 51 54 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 329 335 <span type="species:ncbi:562">E.coli</span>
###xml 404 407 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
Organization of the HCV genome and localization of HCV transcripts in the viral genome. Relative location of the 5'-UTR structural genes (C, Core; E1 and E2, envelope genes 1 and 2), the p7 coding region and non-structural genes (NS2 to NS5) and the 3'-UTR. S1 (1-570), S2 (1-466), S3 (1-402) have been used as substrates in the E.coli RNase III assays. All transcripts initiate at the first base of the HCV genome, contain the complete 5' UTR and expand to different sites within the Core-coding region.
###end p 152
###begin p 153
###xml 82 83 82 83 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 84 85 84 85 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 105 111 105 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E.coli</italic>
###xml 189 190 189 190 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 403 404 403 404 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 502 503 502 503 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 549 555 549 555 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E.coli</italic>
###xml 568 569 568 569 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 44 47 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 105 111 <span type="species:ncbi:562">E.coli</span>
###xml 538 541 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 549 555 <span type="species:ncbi:562">E.coli</span>
Localization of RNase III cleavage sites on HCV transcripts in the viral genome. (A-C) Autoradiograms of E.coli RNase III cleavage of internally labeled, 5' end-labeled and 3' end-labeled S1 transcripts, respectively. Lane 1, the transcript alone incubated on ice; lane 2, transcript incubated in under 'working conditions'; lane 3, RNase III cleavage reaction. The arrows indicate the substrate band (S1) and the product bands-partial products (P1-P2) and (P2-P3) and total products (P1, P2 and P3). (D) Diagram of the cleavage sites of HCV RNA by E.coli RNase III. S1 transcript (1-570) is represented with a line. RNase III cleavage sites in the positions 27, 33 and 439 respectively, are indicated by three arrows. Below are represented the final and partial cleavage products bands observed on a 4% polyacrylamide electrophoresis gels, (P1, P1', P2 and P3) and (P1-P2, P2-P3), respectively.
###end p 153
###begin p 154
###xml 60 61 60 61 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 129 130 129 130 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 154 155 154 155 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 204 205 204 205 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 250 258 250 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2</xref>
###xml 360 361 360 361 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 504 505 504 505 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 999 1000 999 1000 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 1063 1064 1063 1064 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1101 1103 1101 1103 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 1204 1205 1204 1205 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*</sup>
###xml 1292 1293 1292 1293 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1322 1323 1322 1323 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1408 1409 1408 1409 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*</sup>
###xml 1417 1418 1417 1418 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 1477 1478 1477 1478 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*</sup>
###xml 1720 1721 1712 1713 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 1725 1726 1717 1718 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 1774 1775 1766 1767 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1793 1794 1785 1786 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*</sup>
###xml 1964 1967 1956 1959 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">442</sup>
###xml 1973 1976 1965 1968 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">450</sup>
###xml 2026 2027 2018 2019 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*</sup>
###xml 2138 2141 2130 2133 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">439</sup>
###xml 2147 2150 2139 2142 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">440</sup>
###xml 43 46 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
Determination of the cleavage sites in the HCV transcript. (A) To determine the cleavage sites near the 5' end, a 'Cap' labeled S1 was prepared. Lane 1, S1 RNA transcript alone incubated on ice; lane 2, S1 incubated with RNase III (see conditions in Figure 2). Arrows indicate the most prominent bands (P1, P1'); lane 3, alkaline hydrolysis reaction; lane 4, S1 RNase P1 reaction; lane 5, RNA molecular weight markers composed of transcripts with a length of 21, 40, 69, 76, 77, 109 and 135 nt; lane 6, S1 incubated under 'working' conditions buffer without enzyme. Samples were electrophoresed on a 20% denaturing polyacrylamide gel. The RNase III cleavage products (with expected 3' OH end groups) run between two alkaline hydrolysis products (mixtures of RNA fragments with 3'P and 2'P end groups), and have been numbered according to the band running faster. Further experiments based on fingerprinting of internally labeled RNA are in progress to confirm the cleavage position presented here. (B) For determination of the cleavage site near the 3' end, the S2 (1-465) transcript was labeled with 32pCp at its 3' end with the T4 RNA ligase, cleaved with RNase III, and the most 3'-proximal product P3* (indicated by an arrow) gel purified on a 20% denaturing polyacrylamide gel. Lane 1, S2 transcript on ice; lane 2, S2 treated with RNase III (standard conditions); lane 3 and 4, partial hydrolysis of P3* with OH- after incubations of 4 and 8 min, respectively; lane 5, P3* alone; lanes 6 and 7, partial digestions with nuclease T1 at 0.01 and 0.02 microg/microl final concentrations, respectively. The product bands of RNase T1 identified as A, B, C, D, E, at the left of the electrophoresis gel are described in (D). (C) Representation of the 3' end RNA sequence of S2 containing the P3* fragment. RNase T1 cleavages after every G-residue are marked. A gap of 8 nt between the B and C product bands in the gel could be clearly positioned between positions U442 and G450, the largest RNase T1 digestion product of the P3* fragment. This gap serves as a reference to localize the cleavage site two positions upstream, between bases G439 and A440.
###end p 154
###begin p 155
###xml 76 77 76 77 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 277 278 277 278 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 314 316 314 316 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 433 434 433 434 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 437 438 437 438 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 529 531 525 527 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 700 701 696 697 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 857 858 853 854 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 945 946 941 942 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 1045 1046 1041 1042 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 1063 1064 1059 1060 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 1193 1194 1189 1190 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 32 35 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
Biochemical characterization of HCV RNase III cleavage product end-groups. S1 was internally labeled at low specific radioactivity and cleaved with RNase III. P2 purified from the gel was subjected to different specific enzymatic reactions to determine chemical groups of the (A): 3' end. Lane 1, P2 labeled with [32P]pCp and T4 RNA ligase; lane 2, P2 alone; lane 3, control bands resulting from a standard reaction of RNase III on S1. (B) 5' End. Lane 1, P2 central product band labeled with T4 polynucleotide kinase and [gamma-32P]ATP after treatment with alkaline phosphatase; lane 2, P2 was identically treated as before without prior incubation with alkaline phosphatase; lane 3, P2 untreated. (C) 3' and 5' ends by P2 product circularization: lane 1, P2 alone; lane 2, P2 circularization with T4 RNA ligase. The band that corresponds to circularized P2 migrates more slowly than the starting material; lane3, standard RNase III reaction. (D) Coincident mobility of the 5'-terminal RNase III and nuclease P1 cleavage products of substrate S1 5' Cap labeled S1 incubated with: lane 1, RNase III (the positions of the products P1 (27 nt) and P1' (33 nt) are indicated by arrows); lane 2, OH- hydrolysis; lane 3, nuclease P1 treatment.
###end p 155
###begin p 156
###xml 133 134 133 134 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 158 159 158 159 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 170 171 170 171 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 471 472 471 472 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 615 616 615 616 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 619 620 619 620 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 836 837 836 837 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 1196 1197 1188 1189 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 1307 1330 1299 1322 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Penicillium chrysogenum</italic>
###xml 98 101 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 684 687 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 827 830 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 1307 1330 <span type="species:ncbi:5076">Penicillium chrysogenum</span>
Competition assays. (A and B) dsRNA competes with and inhibits the RNase III-specific cleavage of HCV RNA. Cleavage by RNase III of S1 transcript labeled at (A) 5' end; (B) 3' end, in the presence of increasing concentrations of competitor dsRNA. (A) Lanes 1 and 2 correspond to 5' end-labeled RNA alone (incubated on ice) and incubated with buffer, respectively; lane 3, standard reaction with RNase III; lanes 2-9, cleavage reactions using a constant concentration of S1 (10 ng) and increasing concentrations of dsRNA (20, 40, 60, 80, 100 and 120 ng, respectively). (B) Identical to (A) but using 3' end-labeled S1. (C) Reverse competition of RNase III cleavage of T7 R1.1 RNA with HCV RNA. A constant amount of a 60 nt fragment of T7 R1.1 RNA (internally labeled) was cleaved in the presence of increasing concentrations of HCV RNA S1 without label. Lane 1 and 2, RNA T7 R1.1 alone or incubated with buffer, respectively; lane 3, standard RNase reaction, but with final concentration of RNase III of 0.0001 U/microl; lane 4, standard reaction with RNase III (0.0005 U/microl); lanes 5-9, RNase III cleavage of a constant concentration of T7 R1.1 RNA (1.8 nM) and increasing concentrations of S1 RNA (0.45, 0.9, 1.8, 3.6 and 7.2 nM respectively); lane 9, inhibition of T7 R1.1 RNA cleavage with 300 ng of Penicillium chrysogenum dsRNA (positive control).
###end p 156
###begin p 157
Characterization of commercial RNase III secondary cleaving activity in comparison to the natural enzyme. Activity of the natural and commercial RNase III in buffer under working conditions (lower salt). Lane 1 is the R1.1 substrate incubated in buffer alone-it runs as band A. Lanes 2-4, natural RNase III and R1.1 substrate incubated in the presence of 9, 3 and 1 microg of poly(I-C) dsRNA competitor; lane 5, control reaction with no dsRNA; lanes 6-9 all contain substrate and 1 microl of Ambion RNase III at a 1/100 dilution; lanes 6-8 contain decreasing dsRNA competitor as in lanes 2-4, while lane 9 contains no dsRNA; lanes 10-13 are identical to lanes 6-9, except that they contain 1 microl of 1/10 Ambion RNase III. At the lower enzyme: substrate ratio, bands C and D are only faintly present, and they disappear at once when the dsRNA competitor is added.
###end p 157
###begin p 158
###xml 91 97 91 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E.coli</italic>
###xml 266 267 266 267 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 590 591 584 585 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 605 606 599 600 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 753 759 743 749 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E.coli</italic>
###xml 1177 1178 1149 1150 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 1794 1795 1766 1767 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 1799 1805 1771 1777 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E.coli</italic>
###xml 27 30 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 91 97 <span type="species:ncbi:562">E.coli</span>
###xml 120 123 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 268 271 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 381 384 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 425 428 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 753 759 <span type="species:ncbi:562">E.coli</span>
###xml 809 814 <span type="species:ncbi:4932">yeast</span>
###xml 1799 1805 <span type="species:ncbi:562">E.coli</span>
The 5' and 3' cleavages in HCV RNA occur in a single structural motif. Kinetic analysis of E.coli RNAse III cleavage of HCV RNA in the presence or absence of a complementary RNA oligonucleotide. Left panel: autoradiogram of RNase III cleavage of internally labeled S1 HCV RNA transcript in the presence (+) or in the absence (-) of a synthetic RNA oligonucleotide complementary to HCV nt 23-43 (5'-GGAGUGAUCUAUGGUGGAGUG-3'). HCV RNA substrate (0.6 nM final concentration) was pre-heated at 90degreesC for 1 min, before the addition of reaction buffer [10 mM HEPES-KOH, pH 7.5, 10 mM Mg(OAc)2 and 100 mM NH4(OAc)] and left to cool down to room temperature. Cleavage reactions were performed with 20 U RNAsin, and 0.0005 U/microl (final concentration) of E.coli RNase III, in the presence of 1 microg/microl of yeast tRNA, and carried out at 37degreesC in a volume of 10 microl for 1 h. These optimal conditions were used in all of the experiments. In (+) reactions the synthetic complementary RNA oligonucleotide was added to a final concentration of 15 nM. Lane 13 ('M') contains RNA molecular weight markers composed of transcripts with a length of 82, 99, 110, 400 and 570 (S1) nt. Lanes starting from the left represent sequentially 10, 20, 30, 40, 50 and 60 min of incubation with RNase III without (-) or with (+) complementary RNA oligonucleotide. Cleavage products were separated on 4% denaturing polyacrylamide gels and visualized by autoradiography. The arrows on the left indicate the products of the RNase III cleavage directed by the complementary oligonucleotide and on the right; the products of RNase III alone (P1+P2, P2 and P3) are indicated. Quantitation was performed with a Radioisotopic Image Analyzer. Right panel: Graphic representation of the time course processing of S1 by E.coli RNAse III in the absence of the complementary RNA oligonucleotide.
###end p 158
###begin p 159
###xml 112 115 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 223 226 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 407 412 <span type="species:ncbi:9606">human</span>
Diagram including the proposed structural motif which contains both RNase III cleavage domains and encloses the HCV IRES. On the left is shown the interaction between nt 24 and 38 of the 5' (UTR) with the nt 428-442 of the HCV Core-coding sequence. The arrows represent the RNase III cleavage sites. The 'loop' is shown within a box on the right of the figure. Symbol 'P' refers to the cleavage position of human RNase P, which is another RNA structure dependent nuclease. After the annealing, both RNase III and RNase P cleavage sites became in close proximity.
###end p 159

